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Abstract
With an emerging interest in personalized medicine and quality healthcare, the design
of clinical trials that incorporates multiple stages of randomization and intervention, for
example, a sequential multiple assignment randomized trial (SMART), has become a
popular choice for investigators as it facilitates the construction and analysis of dynamic
treatment regimes (DTRs). There exists a comprehensive body of literature on various
statistical methods to analyze data collected from such trials and estimate the optimal
DTR for an individual subject, among which Q-learning with linear regression is widely
used due to its simplicity and ease of interpretation. This thesis discusses three impor-
tant challenges that cause problems in the implementation of Q-learning and proposes
multiple modifications of Q-learning to address them.
The first challenge arises from the repeatedly monitored outcome of interest at in-
termediate stages of randomization and at longer follow-up intervals after the final stage
of randomization. Clinical investigators are usually interested in identifying the optimal
DTR and estimating the outcome trajectory under the optimal DTR. However, in the
presence of stagewise repeated-measures outcomes, standard Q-learning fails to provide
point estimates of the optimal trajectory with time-specific heterogeneous causal effects.
To address this problem, we propose a modified algorithm of Q-learning with a gener-
alized estimating equation to estimate each Q-function. The second challenge is model
misspecification. Model misspecification is a common problem in Q-learning, but little
attention has been given to its impact when treatment effects are heterogeneous across
subjects. We describe the integrative impact of two possible types of model misspecifica-
tion related to treatment effect heterogeneity: unexplained early-stage treatment effects
in late-stage main effect model, and misspecified linearity between pseudo-outcomes and
predictors as a result of the optimization operation. The proposed method, aiming to
deal with both types of misspecification concomitantly, builds interactive models into
iv
residual-modified parametric Q-learning. The third challenge is generalizing modified
Q-learning to dichotomous outcomes. It is difficult to include informative residuals from
estimation of late-stage models into early-stage pseudo-outcomes due to the non-identity
link function. We propose a modification based on monotonicity of preferences to ad-
dress model misspecification in Q-learning with probit regression. The improvement
in robustness of the proposed modification is subject to the extent of model misspec-
ification and can be limited. Thus, we take a latent variable approach and propose a
novel algorithm using sampled surrogates of the underlying continuous outcome condi-
tional on the binary observations. The methods proposed in this thesis are assessed via
simulations and illustrated using the M-bridge study, a SMART with embedded tailor-
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With an increasing demand for quality healthcare and precision medicine, dynamic
treatment regime has become an emerging field for statistical researchers. A dynamic
treatment regime (DTR) (Murphy, 2003; Orellana et al., 2010; Chakraborty and Mur-
phy, 2014; Laber et al., 2014), also known as adaptive intervention (Collins et al., 2004;
Murphy et al., 2007; Lei et al., 2012; Nahum-Shani et al., 2020), or adaptive treatment
strategy (Lavori and Dawson, 2000; Murphy and McKay, 2004; Kosorok and Moodie,
2015), is a sequence of functions, one for each decision, which map from a participant’s
history of characteristics and actions to a set of possible subsequent actions to take over
time. The actions in general can be, depending on the context, treatments or inter-
ventions, and will be used interchangeably in this thesis. Such treatment regimes are
dynamic because individualized treatments vary according to tailoring variables (Collins
et al., 2004; Nahum-Shani et al., 2012). An example of a tailoring variable is whether a
participant responds to the treatment assigned at the first stage, and the correspond-
ing DTR might prescribe that responders continue the initial treatment at the second
stage, whereas non-responders switch to an alternative treatment. This adaptive and
1
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sequential nature of treatment assignments take patient heterogeneity into account and
effectuates personalized medicine.
The sequential multiple assignment randomized trial (SMART) (Murphy, 2005a;
Lavori and Dawson, 2014; Collins et al., 2007) is an experimental design that allows
multiple stages of randomization and collects longitudinal data over these stages to help
construct and analyze DTRs. The two main goals of analyzing the data collected from
SMART studies are: (1) comparison between embedded DTRs, and (2) estimation of
the optimal DTR. The former approach aims to analyze deterministic dynamic regimes,
whereas the latter takes advantage of sequentially accrued information to individualize
treatment at subsequent stages so that the subject ends up with the best possible
result. This thesis focuses mainly on identifying the sequence of decision rules that
optimizes the outcome in question and estimating this value at each time point of
interest. Various methods to address this problem were proposed and discussed in
literature. Chakraborty and Murphy (2014) presented a comprehensive description of
direct and indirect methods to identify the optimal DTR, direct methods being marginal
structural models (Robins, 2000a,b) and inverse probability of treatment weighting, and
indirect methods including Q-learning and dynamic system models.
1.2 Q-learning: A Backward Induction Algorithm
Q-learning (Watkins, 1989) is a dynamic programming (Bellman, 1957) algorithm and
has been widely implemented to identify the optimal DTR (Murphy and McKay, 2004;
Nahum-Shani et al., 2012). At each stage of randomization, Q-learning specifies a model
of expected outcomes conditional on past history, given that the optimal interventions
are followed thereafter. The parametric form of the conditional expectation is called a
Q-function (Sutton and Barto, 1998; Murphy, 2005b) and is usually written as a linear
regression. Model parameters are estimated stagewise using backward induction (Au-
mann, 1995). In classification problems, the Q-functions may be estimated by regression
3
trees or kernels.
Suppose the longitudinal data collected from a SMART study are
(Z1, A1, Z2, A2, . . . , Zk, Ak, . . . , ZK , AK , Y )
for stages k = 1, . . . ,K, where Zk denotes the observed covariates and intermediate
outcomes which are measured prior to randomization at stage k, Ak ∈ Ak denotes the
treatment received at stage k, and Y denotes the final outcome of interest with small
values preferred. Let Hk = (Z1, A1, . . . , Zk−1, Ak−1, Zk) be the history of covariates and
treatments prior to randomization at stage k.
Optimization of DTRs borrows the concept of potential outcomes, and therefore the
following causal assumptions are necessary:
• Consistency: The potential outcome under the observed treatment agrees with
the observed outcome;
• No unmeasured confounders, also known as sequential ignorability: Ak is inde-
pendent of all future potential outcomes, conditional on the history Hk.
The no unmeasured confounders assumption is valid with the sequential randomization
of a SMART.
The Q-function at stage k, Qk(Hk, Ak), is a function of the observed history up to
stage k and the treatment received at stage k, and usually consists of a main effect
model and a treatment effect model.
Starting from the last stage, the linear regression model is specified as
QK(HK , AK) = E(Y |HK , AK) = xTK0βK +AKxTK1ψK ,
where xK0 and xK1 are realizations of functions of HK that represent the covariates in
the main effect and treatment effect model respectively. The least squares estimators
of stage K parameters, β̂K and ψ̂K , are obtained.
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For a precedent stage k, k = K − 1,K − 2, . . . , 1, the Q-function is specified as




Qk+1(Hk+1, Ak+1 = ak+1)
∣∣∣∣Hk, Ak] = xTk0βk +AkxTk1ψk,
where xk0 and xk1 are realizations of functions of Hk. The least squares estimators of
stage k parameters, β̂k and ψ̂k are obtained.
The estimated optimal DTR is
(
d̂opt1 , . . . , d̂
opt





d̂optk = arg min
ak∈Ak
Qk(Hk, Ak = ak; β̂k, ψ̂k).
We assume a two-stage setting throughout the thesis, where K = 2.
1.3 The M-bridge Study
Figure 1.1: The M-bridge study: a sequential, multiple assignment, randomized trial.
This figure is adapted from the figure of study design in Patrick et al. (2020). R
indicates a randomization stage with arrows pointing to available treatment options, and
A indicates time of assessment where measurements of intermediate or final outcome
take place.
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The M-bridge study (Patrick et al., 2020) is a SMART conducted at the Univer-
sity of Minnesota Twin Cities. The study develops and evaluates an adaptive pre-
ventive intervention for college drinking and related problems among first-year college
students. As illustrated in Figure 1.1, enrolled students were randomized to receiv-
ing a combined universal preventive intervention, personalized normative feedback and
self-monitoring (PNF+SM), either prior to attending college (early intervention) or in
the first month of the first semester (late intervention). Two intermediate measures of
alcohol use, namely, the frequency of binge drinking (consuming 4/5+ drinks in a row
for women/men) and the frequency of high-intensity drinking (consuming 8/10+ drinks
in a row for women/men) in the past two weeks, were self-monitored and recorded by
students. Prior to re-randomization, students were flagged as a “heavy drinker” if they
report two or more occasions of binge drinking, or one or more occasion of high-intensity
drinking during a two-week self-monitoring period; otherwise, they were flagged as a
“non-heavy drinker”. This is a tailoring variable embedded in the SMART design, and
the set of available intervention options at stage 2 depended on this tailoring variable.
Heavy drinkers were re-randomized to receiving the indicated intervention of an au-
tomated email or an invitation to online health coaching, whereas non-heavy drinkers
continued self-monitoring for the rest of the first semester. The adaptive design helps
to determine whether more resources should be allocated to bridge the students to
indicated interventions for alcohol use. The investigators collected a variety of continu-
ous and dichotomous outcomes related to drinking behavior, consequences, and health
services utilization.
1.4 Outline
This thesis discusses three challenges and concerns associated with the implementation
of Q-learning in various contexts, and develops multiple modifications of Q-learning to
address these problems. Chapter 2 is motivated by SMARTs with repeated-measures
6
outcomes at each stage. We develop Q-learning with generalized estimating equations
which aims to generate an optimal trajectory considering all measurement times. One
existing modification to Q-learning with Murphy’s regret function (Murphy, 2003), that
acts as a fundamental thought upon which this thesis is written, was proposed by Huang
et al. (2015) and takes care of as much residuals from model misspecification as possi-
ble. To increase robustness, we then build Murphy’s regret function into the proposed
method. The susceptibility of the modified algorithm to different correlation structures
and model misspecification will be explored through simulation studies. Chapter 3
considers modifications of Q-learning that specifically tackle model misspecifications as-
sociated with treatment effect heterogeneity. Some theoretical results will be derived to
understand how unmeasured variables in the stage 2 main effect model affect stage 1
estimation, where omission of stage 1 treatment effects is a specific case. We propose to
build interactive model (Laber et al., 2014) into residual-modified Q-learning to correct
the bias generated as a result of heterogeneous treatment effects at both stages. Finally,
Chapter 4 generalizes this approach to dichotomous outcomes. The feasibility to develop
a robust algorithm to correctly identify the optimal DTR with dichotomous outcomes
will be briefly discussed. It is indeed difficult to incorporate residual remainders from
estimation of late-stage models into early-stage pseudo-outcomes. Instead, we develop
a simple but nontrivial modification to Q-learning with probit regression by imposing
monotonicity of preferences. The advantages and drawbacks of this modified algorithm
will be demonstrated using simulation studies. We also propose an alternative approach
using latent variable modeling and develop a novel algorithm that incorporates Mur-
phy’s regret function to sampled surrogates of the underlying latent variable. All the
proposed modifications will be illustrated using the data collected from the M-bridge
study. A different structure of the M-bridge data may be used in each chapter, and the







In some SMARTs, investigators collect repeated-measures outcomes at one or more
stages to monitor longitudinal treatment effects, especially at the final stage. This
chapter is motivated by two such studies, the M-bridge study and the developmental
language disorder (DLD) study. In the M-bridge study (Figure 1.1), the primary out-
come is the frequency of binge drinking during a 30-day period and there was a baseline
measurement before the randomization stages. The frequency of binge drinking over the
past two weeks was recorded at the end of stage 1 intervention via self-monitoring. We
multiply this frequency by 2 to give the approximate monthly frequency. The investi-
gators repeatedly monitored the frequency of binge drinking thereafter, with follow-up
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assessments immediately at the end of the first semester and at the end of the sec-
ond semester. The DLD study evaluates a sequence of treatments for children with
developmental language disorder (Finestack, 2018), and has a similar design. The in-
vestigators have a scientific interest in sustained treatment effects, so the participating
children’s performance was repeatedly assessed at 1, 6, and 12 months after the end
of the treatment period (additional details can be found in Appendix A.2). The data
from the DLD study are not available for analysis at the time of writing, so we will
use the M-bridge study to illustrate our framework and method throughout the chap-
ter. Recently, SMARTs with repeated-measures outcomes at one or more stages are of
growing interest in literature, with the autism study (Kasari et al., 2014), the ENGAGE
study (McKay et al., 2015), and the PLUTO study (Fu et al., 2017) as examples. The
stagewise repeated measures provide information on the treatment effects from previ-
ous stages over time and motivate the development of new methodologies to adequately
incorporate these additional follow-ups into statistical analysis.
The two main goals of statistical analysis for SMART studies often are (1) com-
paring embedded DTRs, and (2) estimating the optimal DTR. The first goal aims
to estimate the marginal benefit of each DTR embedded in the SMART. For exam-
ple, there are four embedded DTRs (or adaptive preventive interventions) in the M-
bridge study: Early/Email, where first-year college students participated in PNF+SM
prior to Semester 1, and were bridged to automated emails if they were flagged as
heavy drinkers or continued self-monitoring if they were flagged as non-heavy drinkers;
Early/Coach, where students were bridged to online health coach if they were flagged
as heavy drinkers; Late/Email, where students participated in PNF+SM during the
first month of Semester 1, and were bridged to automated emails if they were flagged
as heavy drinkers; Late/Coach, where students were bridged to online health coach if
they were flagged as heavy drinkers. The existing method to estimate the longitudinal
trajectory of these embedded DTRs is the weighted and replicated GEE (Lu et al.,
9
2015). The second goal takes advantage of subject heterogeneity to identify the opti-
mal DTR for each subject. The optimal DTR is a sequence of decision rules, one for
each intervention stage, that optimize the expectation of an outcome of interest. In
the M-bridge study, smaller values of the outcome are preferred. In addition, the in-
vestigators are interested in estimating the longitudinal trajectory of the optimal DTR
and the heterogeneous causal effects at each stage to understand how the optimal DTR
affects the outcome over time. The reasons for doing so might be to simply visualize
the marginal trajectory of outcomes under the course of optimal regime, or to address a
scientific interest, for example, if any DTR-specific trajectory almost coincides with the
optimal trajectory. To the best of our knowledge, there is a lack of methods to tackle
potential challenges in the optimization problem with repeated-measures outcomes. In
this chapter, we propose some modifications of the Q-learning algorithm to address this
issue.
One of the challenges in this context is to incorporate the longitudinal outcomes,
whose clinical importance may differ according to the time of measurement. Classic
Q-learning algorithm can deal with the repeated measures by simply collapsing them
to a composite value, usually through a weighted sum. However, it fails to estimate
the trajectory of heterogeneous causal effects or expected outcomes over the entire
time period of interest. Thus, we propose to write the Q-functions as marginal models
possibly with time-varying coefficients and estimate model parameters using generalized
estimating equations (GEEs). Moreover, there is a possibility to misspecify the late-
stage model. In the M-bridge study, some important interactions between baseline
covariates and stage 1 intervention may be neglected when constructing the stage 2
model. To address this problem, we modify the proposed method with Murphy’s regret
function (Murphy, 2003; Huang et al., 2015).
We proceed by first formulating the causal framework to identify the optimal DTR
and estimate the heterogeneous causal effects in Section 2.2. Furthermore, the details of
our proposed method are explained in Section 2.3. Section 2.4 presents a comprehensive
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simulation study to explore the susceptibility of the proposed method to different corre-
lation structures between repeated-measures outcomes and model misspecification. We
then apply modified Q-learning with GEE in Section 2.5, and compare the optimal tra-
jectory with marginal trajectories of the embedded DTRs, which can also be estimated
as a by-product of the method. Finally, we conclude with a brief discussion.
2.2 Statistical Framework for a SMART with Repeated-
measures Outcomes
2.2.1 Causal Framework
Suppose that the longitudinal data collected from a SMART with repeated-measures
outcomes are represented by a sequence of random variables (Z1, A1,Y1, Z2, A2,Y2),
where Z1 is the set of baseline covariates and outcome measured prior to stage 1 ran-
domization, Z2 is the set of time-varying covariates and tailoring variables measured
after stage 1 and before stage 2 randomization, and Ak ∈ Ak, k = 1, 2, is the treatment
that the participant receives at stage k, with Ak being the set of all possible treatments.
In the M-bridge study, A1 = {−1, 1}, where A1 = 1 represents early intervention and
A1 = −1 represents late intervention, and A2 = {−1, 1}, where A2 = 1 represents online
health coach and A2 = −1 represents automated email. Y1 is the outcome measured
between stage 1 and stage 2 treatments, and Y2 is the outcome measured after stage
2 treatment. This framework is generalized to stagewise repeated-measures outcomes,
so both Y1 and Y2 can be vectors. In the M-bridge study, Y1 is a scalar and Y2 is a
vector. Our framework and method are flexible in both contexts, as long as we have
repeated-measures outcome for at least one stage. In the M-bridge study, the outcome
is the frequency of binge drinking, with smaller values preferred. Now let H1 = Z1 and
H2 = (Z1, A1,Y1, Z2) denote the covariate and treatment history up to the stage 1 and
stage 2 randomization respectively.
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Recall that the desired decision rules may not be the same as the observed ones, so
solving the problem requires the concept of potential outcomes and naturally falls into
the causal framework. For k = 1, 2, let Āk = (A1, . . . , Ak) be a stochastic sequence of
treatments up to stage k, with values āk = (a1, . . . , ak). Define Y
āk
k to be the potential
outcomes at stage k under the treatment sequence āk. In the context of repeated-
measures outcomes, we rewrite the causal assumptions:
• Consistency: Let Yk be the observed outcome at stage k under the treatment














1 if Āk = āk
0 if Āk 6= āk
is an indi-
cator function.
• No unmeasured confounders, also known as sequential ignorability: For any treat-
ment sequence āk−1 prior to stage k, Ak is independent of all future potential out-




k : ak ∈ Ak
}
⊥ Ak | Hk.
This assumption is satisfied in a SMART due to stagewise randomization.
Let dk : Hk 7→ Ak be the decision rule at stage k with dk = dk(Hk) for Hk ∈ Hk,
where Hk is a set of all possible history information prior to stage k. Applying the
causal framework discussed by Chakraborty and Murphy (2014), the expected potential




























EY2|H2,A2(Y2|H2, A2 = a2)︸ ︷︷ ︸
(a)




This causal framework allows for estimation of expected potential outcomes using ob-
served outcomes, and it is straightforward to generalize it to more than two stages. The
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doubly-iterated expectation in Equation (2.1) provides a mathematical guidance for im-
plementing Q-learning. Here, (a) and (b) are the key estimands and will be used to
construct estimands to address the scientific problems of interest. We will discuss these
estimands in greater detail in Section 2.2.2. The vector nature of Y1 and Y2 inspires
the use of GEE techniques (Zeger and Liang, 1986) to estimate them, which will be
discussed in Section 2.3.
2.2.2 Optimization Problem
There are four main scientific problems we would like to address in this chapter: (1)
to identify the optimal decision rule at each stage as a function of the history prior
to that stage, (2) to estimate the optimal trajectory over time, (3) to estimate the
heterogeneous causal effects of stage 2 treatment over time, conditional on the history
prior to stage 2, and (4) to estimate the heterogeneous causal effects of stage 1 treatment
over time, provided that participants follow the optimal treatment at stage 2. Note
that the outcome of interest is formed by a sequence of vectors, and it is impossible
to minimize a vector without any partial orders. Scientifically, the importance of these
outcomes may vary based on the time of measurement, and it is for clinical investigators
to decide. Thus, we assign weights wk to each Yk, k = 1, 2, where elements of wk are
nonnegative, and the scalar
2∑
k=1
wTk Yk is the target of optimization. Since outcomes
with smaller magnitude are more desirable in the M-bridge study and elements of wk
are nonnegative, smaller values of
2∑
k=1
wTk Yk are preferred.
The underlying estimands in the above-mentioned scientific problems can be ex-
pressed using (a) and (b). We restrict the problem in the comparison between two
available treatments at a specific stage, as described in the M-bridge study. The frame-
work can be generalizable to multiple treatment options, with treatment effects defined
through pairwise comparison and contrasts.
Conditional on the history prior to stage 2, the heterogeneous causal effects, also
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known as conditional average treatment effects (CATE) (Abrevaya et al., 2015), or
moderated causal effects (Wodtke and Almirall, 2017) of stage 2 treatment over time,
are defined as
τ2(H2) = E(Y2|H2, A2 = 1)− E(Y2|H2, A2 = −1). (2.2)







−1 if x < 0
1 otherwise
.
Suppose the subjects follow the optimal treatment at stage 2, the heterogeneous







∣∣H2, A2 = dopt2 )







∣∣H2, A2 = dopt2 )
∣∣∣∣∣∣H1, A1 = −1
 ,
(2.3)














2 (H2) in Equation (2.1).
2.3 Modified Q-learning with Generalized Estimating Equa-
tions
Q-learning is a widely implemented algorithm to identify the optimal DTR. It is also
discussed in literature (Huang et al., 2015) that the expected trajectory of embedded
treatment regimes can be estimated as a by-product of Q-learning. Instead of speci-
fying a simple linear regression for each Q-function, we propose to utilize a marginal
model that can generate point estimates at all measurement times. GEE techniques
are then used to estimate the model parameters, taking advantage of the robustness to
misspecification of working covariance matrix.
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2.3.1 Composite Q-learning
Suppose (Z1i, A1i,Y1i, Z2i, A2i,Y2i) is the sample data collected for subject i, i =
1, . . . , n. In order to apply the standard Q-learning algorithm, we could collapse repeated-
measures outcomes using a weighted sum, and the Q-functions are defined as:








H2i, A2i = d
opt
2
)∣∣∣H1i, A1i) , (2.4)
where wk is a clinically specified weight vector for outcomes at stage k, as described in
Section 2.2.2. Consider Q-functions of the parametric form




k1,iψk, k = 1, 2, (2.5)
where xk0,i and xk1,i are realizations of functions of Hki. Starting from stage 2, β̂2 and
ψ̂2, are obtained using least squares estimation. Stage 1 estimators, β̂1 and ψ̂1, are




H2, A2 = a2; β̂1, ψ̂1
)
on H1 and A1. We
term this type of Q-learning as composite Q-learning.
2.3.2 Q-learning with Generalized Estimating Equations
Our proposed method does not collapse repeated-measures outcomes but treats repeated-
measures outcomes as a vector. Let tk = (tk1 . . . tkj . . . tkJk)
T be a vector of all mea-
surement times right after the treatment period at stage k, including measurements at
future stages. Throughout the chapter, we assume that measurements are taken at the
same time across subjects. Therefore, the Q-functions are re-defined as
Q2(H2i, A2i, t2) = E (Y2i|H2i, A2i) ,












Consider a linear model with time-varying coefficients βkj and ψkj




k1,iψkj , j = 1, . . . , Jk, k = 1, 2, (2.7)
and Qk = (Qk1 . . . Qkj . . . QkJk)
T . Thus, βk =
(
βTk1 . . . β
T







ψTk1 . . . ψ
T




are the parameters to be estimated at stage k.




TV −12 {Y2i −Q2 (H2i, A2i, t2;β2,ψ2)} = 0, (2.8)







) and V2 is the working covariance for Var(Y2|H2, A2).









 = 0, (2.9)
where

















H2i, A2i = d̂
opt
2i , t2; β̂2, ψ̂2
)
,






The GEE approach allows for missingness in responses over time. Taking the M-
bridge study as an example, we have missingness in stage 1 outcome and stage 2 outcome
at both follow-ups. Since the outcomes depend only on covariates, we should have a
complete set of baseline and intermediate covariates for model estimation at each stage.
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An issue with respect to the estimation procedure in Q-learning is that stage 2 outcome
depends on stage 1 outcome. Hence, missingness in stage 1 outcome causes problems in
stage 2 estimation. The design of the M-bridge study obviates this issue by introducing
the tailoring variable. The tailoring variable, whether the students were flagged as
heavy drinkers, is defined based on the stage 1 outcome, and those with missing stage
1 outcomes were not flagged as heavy drinkers. Since only heavy drinkers were re-
randomized at stage 2, the students we include in stage 2 estimation all have complete
covariate data.
In practice, choosing a wrong working structure for V1 and V2 can raise issues in
estimation. Liang and Zeger (1986) argued that there was little difference in estimation
of parameters when the true correlation was moderate. Zhao et al. (1992) claimed that
wrong specification of an independent correlation matrix when outcomes were strongly
dependent would result in “important losses of efficiency”, as compared to the smaller
reduction in efficiency when specifying unnecessary high correlations. In the presence of
missingness not completely at random, Fitzmaurice et al. (1993) advocated for obtaining
a close approximation to the covariance structure in outcomes so that the estimators of
time-dependent treatment effects were substantially less biased. SMARTs usually result
in a balanced design with time-invariant covariates. Moreover, the M-bridge study has
relatively few repeated measures at each stage. Considering all these arguments, we
recommend an unstructured working correlation structure.
The estimands discussed in Section 2.2.2 can now be written as functions of pa-
rameter estimates. The estimated optimal decision rule at stage k for individual i is
identified by minimizing a weighted sum of Q-functions at stage k:




H2i, A2i = a2; β̂2, ψ̂2
)
,









H1i, A1i = a1; β̂1, ψ̂1
)
. (2.10)
The estimated heterogeneous causal effects at times of interest following the stage k
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treatment period are calculated as:
τ̂k(Hk) = Qk
(




Hk, Ak = −1, tk; β̂k, ψ̂k
)
, k = 1, 2.
(2.11)
2.3.3 Modified Q-learning with Murphy’s Regret Function
Model misspecification is a common issue in the implementation of Q-learning. Q-
learning requires models at all stages to be correctly specified for consistent estimation
of the optimal DTR and heterogeneous causal effects. In this thesis, we assume that the
treatment effect models are correctly specified. Backward induction features multi-stage
analysis, so even without any unmeasured confounders, misspecification of main effect
model at a later stage can bias the estimation of treatment effects at earlier stages, thus
resulting in an adverse impact on identification of the optimal DTR and the estimation
of the optimal trajectory. Because the focus of the stage 2 model is on the estimation
of the stage 2 heterogeneous causal effects, the interaction between baseline covariates
and stage 1 treatment may be overlooked in the stage 2 model. Not adjusting for some
important interactions in the stage 2 model and only including them in the stage 1 model
will result in biased stage 1 treatment effect estimators. In the example of M-bridge, it
is more difficult to select correct Z1 ∗A1 interactions into stage 2 model a priori due to
the large number of baseline covariates that the study is considering. Thus, we would
like to introduce some robustness to our proposed method by borrowing the concept of
modified Q-learning (Huang et al., 2015).
The modified version of composite Q-learning defines the Q-function at stage 1 as




2 Y2i + ∆2i
∣∣H1i, A1i) , (2.12)
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where ∆2i is the Murphy’s regret function at stage 2 and
∆2i =




∣∣∣xT21,iψ2∣∣∣ if A2i 6= dopt2i .
Thus, the stage 1 estimators in modified composite Q-learning are obtained by regressing
wT1 Y1 +w
T
2 Y2i − 2
∣∣∣xT21,iψ̂2∣∣∣1{A2i 6= d̂opt2i } on H1 and A1.
Applying this technique to Q-learning with GEE, our proposed modification to the
algorithm illustrated in Section 2.3.2 updates stage 1 Q-function (2.6) as








 0 if A2i = d
opt
2i




Thus, the stage 1 estimators in modified Q-learning with GEE are obtained using Equa-






. This approach makes as much
use of observations as possible and is robust to misspecification of stage 2 main effect
model.
2.4 Simulation Study
In this section, we present a simulation study to compare the performance of the four
methods illustrated in Section 3.5: (1) composite Q-learning (Q), (2) modified composite
Q-learning (mQ), (3) Q-learning with GEE (Q-GEE), and (4) modified Q-learning with
GEE (mQ-GEE).
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2.4.1 Data Generative Mechanism
For simplicity, we omit any intermediate and tailoring variables in the data generative
mechanism. Assume a sequence of observations from a simple SMART study with
no embedded tailoring variable is (Z1i, A1i, Y1i, A2i,Y2i), i = 1, . . . , n, where Z1i
i.i.d.∼







i.i.d.∼ Bernoulli(0.5). The scalar Y1i ∈ R is the observed
outcome at the end of stage 1. The vector Y2i ∈ R2 is the observed repeated-measures















































We are able to control the direction and magnitude of the conditional covariance
Σ through parameters λ1, λ2, λ3, σe, σv. The existence of conditional covariance can
be viewed as adding an unmeasured covariate to the expected outcomes (refer to Ap-
pendix A.3 for a full derivation). The effects of the unmeasured covariate on Y1 and Y2
can be similar or opposite. Suppose that the parameter values are (α1, α2, α3, γ2, γ3) =
−(2.0, 1.7, 1.6, 1.2, 0.8). The error dispersion is set to σe = 2.7 and σv = 3.2 so that the
marginal coefficient of determination R2 (Zheng, 2000) is around 0.25 to 0.60 for stage
1 model, and around 0.33 to 0.45 for stage 2 model. We will explore the performance
of above-mentioned methods when partial correlations vary in the following cases:
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(I) Y1 and Y2 are not conditionally correlated, λ1 = λ2 = λ3 = 0.
(II) Y1 and Y2 are positively conditionally correlated, λ1 = λ2 = λ3 = 1.
(III) Y1 and Y2 are negatively conditionally correlated, λ1 = 1 and λ2 = λ3 = −1.
2.4.2 Evaluation Criteria












: the probability of correctly identified optimal rules
(PCI) at stage k, where d̂optki is the estimated optimal decision rule at stage k
for subject i using Equation (2.10) with elements of Qk being equally weighted,
and doptki is the true optimal decision rule at stage k for subject i, minimizing the










: root mean square error (RMSE)
of the estimated heterogeneous causal effects of stage 1 treatment at the jth
measurement, j = 1, 2, 3, assuming participants follow the optimal treatment at
stage 2. τ̂1j(Z1i) is the jth element of τ̂1 from Equation (2.11).
(3) Biasτ1j(Z1) = τ̂1j(Z1) − τ1j(Z1) for a grid of values Z1, where τ1j(Z1) is the jth
element of τ1 from Equation (2.3).
RMSE is the standard deviation of prediction errors. RMSEτ1j provides information
on both accuracy and efficiency of using the stage 1 model to estimate heterogeneous
causal effects across samples, and measures how accurate and precise the predicted
heterogeneous causal effects are to the true values of the estimands over a sample of
participants. Biasτ1j(Z1) is composed of two components: (1) the bias from the estima-
tion of stage 2 optimal rule, and (2) the bias from the estimation of stage 1 parameters.
Bias should be heterogeneous across participants and dependent on the value of baseline
measurement Z1.
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True values of the estimands are derived analytically as follows.
Let doptki be the true optimal decision rule at stage k for subject i, minimizing a
weighted average of all outcomes following stage k treatment:


























Let τ1j(Z1) be the expected stage 1 heterogeneous treatment effect at time j conditional








2.4.3 Results for Equally Weighted Outcomes
To apply Q-learning with GEE, H2 = (Z1, A1, Y1) and the interaction between A2 and
H2 are included as covariates in Q2, and H1 = Z1 and the interaction between A1
and H1 are included as covariates in Q1, all with time-varying coefficients. Composite
Q-learning uses the same set of covariates, but without time-varying coefficients. We
consider two scenarios: (I) Q2 is correctly specified with Z1 ∗ A1 in the main effect
model, and (II) Q2 is misspecified by omitting Z1 ∗A1 in the main effect model. Here,
we show the results under weights w1 = 1/3 and w2 = (1/3, 1/3) with a sample size
n = 200. Details of model specifications can be found in Appendix A.4.
22
2.4.3.1 Scenario I: no model misspecification
As shown in Table 2.1 and Figure 2.1(a), there is a tiny loss in the accuracy of identifying
stage 1 optimal rules using Q-learning with GEE as compared to composite Q-learning.
The loss is likely due to the additional time-varying coefficients in the marginal model
that Q-GEE has to estimate and is negligible considering the high accuracy. Q-lGEE
is able to estimate heterogeneous causal effects (Table 2.1 and Figure 2.2(a)), and the
modified version of Q-GEE has exactly the same performance as the standard algorithm.
Partial Correlation Method PCI1 PCI2 RMSEτ11 RMSEτ12 RMSEτ13
Positive
Q 0.950 0.983 - - -
mQ 0.950 0.983 - - -
Q-GEE 0.947 0.983 0.74 (0.38) 0.97 (0.52) 0.94 (0.49)
mQ-GEE 0.947 0.983 0.74 (0.38) 0.97 (0.52) 0.94 (0.49)
Independent
Q 0.976 0.998 - - -
mQ 0.976 0.998 - - -
Q-GEE 0.974 0.998 0.49 (0.26) 0.69 (0.36) 0.68 (0.35)
mQ-GEE 0.974 0.998 0.49 (0.26) 0.69 (0.36) 0.68 (0.35)
Negative
Q 0.970 0.984 - - -
mQ 0.970 0.984 - - -
Q-GEE 0.966 0.984 0.74 (0.38) 0.98 (0.51) 0.94 (0.51)
mQ-GEE 0.966 0.984 0.74 (0.38) 0.98 (0.51) 0.94 (0.51)
Table 2.1: (Scenario I) PCI of optimal rules and RMSE (mean (SD)) of estimated het-
erogeneous causal effects, based on estimated stage 1 Q-functions from 1000 simulations
with sample size n = 200.
2.4.3.2 Scenario II: misspecified stage 2 main effect model
Under this circumstance, mQ-GEE universally outperforms Q-GEE in PCI1 (Table 2.2
and Figure 2.1(b)), the RMSE of predicting heterogeneous causal effects (Table 2.2 and
Figure 2.2(b)), and the bias of estimating heterogeneous causal effects based on a grid
of Z1 values (Figure 2.3(b)). This confirms our hypothesis that modified Q-learning
avoids bias caused by misspecification of stage 2 main effect model. For more extreme
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values of Z1, there exists a remarkable bias (Figure 2.3) using Q-GEE in the presence of
nonzero partial correlations. This bias does not decrease to 0 as sample size increases,
suggesting that Q-GEE estimators are not consistent in this case.
Partial Correlation Method PCI1 PCI2 RMSEτ11 RMSEτ12 RMSEτ13
Positive
Q 0.944 0.990 - - -
mQ 0.951 0.990 - - -
Q-GEE 0.940 0.990 0.73 (0.39) 1.20 (0.56) 1.13 (0.52)
mQ-GEE 0.949 0.990 0.73 (0.39) 0.96 (0.50) 0.96 (0.48)
Independent
Q 0.957 0.995 - - -
mQ 0.973 0.995 - - -
Q-GEE 0.948 0.995 0.49 (0.25) 2.28 (0.55) 2.13 (0.53)
mQ-GEE 0.971 0.995 0.49 (0.25) 0.75 (0.40) 0.73 (0.37)
Negative
Q 0.845 0.954 - - -
mQ 0.965 0.954 - - -
Q-GEE 0.702 0.954 0.74 (0.40) 4.70 (0.76) 4.56 (0.65)
mQ-GEE 0.958 0.954 0.74 (0.40) 1.11 (0.56) 1.05 (0.55)
Table 2.2: (Scenario II) PCI of stage 1 optimal rules and RMSE of estimated heteroge-
neous causal effects at time 2 and 3, based on estimated stage 1 Q-functions from 1000
simulations.
Combining the results in both scenarios discussed above, we can conclude that par-
tially correlated outcomes can be treated as a specific type of model misspecification,
but it cannot be relieved by mQ-GEE for all cases of correlated outcomes. However,
mQ-GEE is a more robust algorithm and has a decent and stable performance over
all cases and metrics. Therefore, mQ-GEE should be used in analyzing SMART data
with repeated-measures outcomes, especially in the case where stage 2 outcomes are
believed to be conditionally negatively correlated with stage 1 outcomes. We also ex-
plored the relative efficiency of estimators under different stage 1 working correlations
(Appendix A.5). With the relatively small data structure (3 repeated measures in total)
in this simulation study and the saturated models considered, the potential impact of
choosing a wrong working correlation matrix is small.
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Figure 2.1: The probability of correctly identifying the optimal rules across a grid of
sample sizes for scenarios (a) when outcomes are correlated, and (b) when outcomes
are correlated and the main effect model in stage 2 Q-function is misspecified, based on
1000 iterations.
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Figure 2.2: Root mean square error (mean and 95% confidence interval) of heterogeneous
causal effects across a grid of sample sizes for scenarios (a) when outcomes are correlated,
and (b) when outcomes are correlated and the main effect model in stage 2 Q-function
is misspecified, based on 1000 iterations.
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Figure 2.3: Bias (mean and 95% confidence interval) of heterogeneous causal effects
across a grid of Z1 for scenarios (a) when outcomes are correlated, and (b) when out-
comes are correlated and the main effect model in the Q-function is misspecified, based
on 1000 iterations.
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2.4.4 Results for Unequally Weighted Outcomes
We run the simulation under a set of different weights. Figure 2.4 shows the result for
the metric PCIk, k = 1, 2. A significant difference in performance between Q-learning
and modified Q-learning is observed for the negatively correlated outcomes, especially
when more weights are assigned to stage 2 outcomes. Figure 2.5 shows the result for
the metric RMSEτ1j , j = 1, 2, 3. The findings are consistent with Section 2.4.3: across
all weights considered, mQ-GEE has a universally better performance than Q-GEE for
all scenarios. The sample size is set at n = 200.
Figure 2.4: The probability of correctly identifying the optimal rules across a set of
weights (w1,w2) for scenarios (a) when outcomes are correlated, and (b) when outcomes
are correlated and the main effect model in stage 2 Q-function is misspecified, based on
1000 iterations.
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Figure 2.5: Root mean square error (mean and 95% confidence interval) of heterogeneous
causal effects across a set of weights (w1,w2) for scenarios (a) when outcomes are
correlated, and (b) when outcomes are correlated and the main effect model in stage 2
Q-function is misspecified, based on 1000 iterations.
2.5 Application
We use the M-bridge study (n = 591) to illustrate the application of mQ-GEE. Our
goal is (1) to identify the optimal rules considering different weights for the repeated-
measure outcomes, (2) to estimate the optimal trajectory and compare it with estimated
trajectories of the four embedded DTRs, and (3) to estimate time-specific heterogeneous
causal effects. The baseline variables considered are gender, race/ethnicity, pre-college
intention to pledge to a sorority or fraternity [i.e., ”Greek”], and baseline drinking
habits. We are interested in the frequency of binge drinking during a 30-day period at
baseline, self-monitoring (stage 1) and follow-up 1 and 2 (stage 2).
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2.5.1 Identification of Personalized Optimal Rules
Applying mQ-GEE and assigning equal weights to each component of Y1 and Y2, we
estimate the individualized optimal decision rules that should be made at each stage
for each college student. Variable selection based on QIC (Pan, 2001) is performed in
this application to avoid over-fitting. The fitted stage 1 model selects gender and time-
varying effects of intention to pledge to Greek and race as tailoring variables, whereas
the fitted stage 2 model selects stage 1 outcome, baseline drinking habits, and time-
varying effects of race and baseline outcome as tailoring variables (Appendix A.7). In
summary, at stage 2, conditional on the covariate and treatment history, 58% of the
heavy drinkers in this study would have benefited more from automated email (A2 = −1)
and 42% would have benefited more from online health coach (A2 = 1). At stage 1,
provided that participants follow the estimated optimal decision rules at stage 2, 22% of
the participants would have benefited from late intervention (A1 = −1) and 78% would
have benefited from early intervention (A1 = 1).
Table 2.3: Summary of estimated stage 1 and stage 2 optimal rules as a proportion of
college students who were eligible for randomization at stage k, k = 1, 2, under different
weights.
w1 w2 Stage 1 Stage 2
a
Q-GEE mQ-GEE
A1 = −1 A1 = 1 A1 = −1 A1 = 1 A2 = −1 A2 = 1
0.33 (0.33, 0.33) 0.22 0.78 0.22 0.78 0.58 0.42
0 (1, 0) 0.67 0.33 0.40 0.60 0.61 0.39
0 (0.5, 0.5) 1 0 0.63 0.37 0.58 0.42
0 (0, 1) 1 0 1 0 0.59 0.41
0.25 (0.5, 0.25) 0.22 0.78 0.54 0.46 0.59 0.41
0.25 (0.25, 0.5) 0.24 0.76 0.63 0.37 0.59 0.41
0.5 (0.5, 0) 0.22 0.78 0.14 0.86 0.61 0.39
0.5 (0.25, 0.25) 0.22 0.78 0.22 0.78 0.58 0.42
aThe percentage of stage 2 optimal rules is calculated based on the total number of heavy drinkers.
Q-GEE and mQ-GEE generate the same results because the corresponding stage 2 models are the same.
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We also explored the performance of Q-GEE and mQ-GEE under different weights.
Table 2.3 shows a summary of the results. The assignment of stage 2 optimal rule is
similar for both methods. However, it seems that mQ-GEE is more sensitive to the
change in weights.
2.5.2 Point Estimation of the Optimal Trajectory and Heterogeneous
Causal Effects
Figure 2.6 shows the estimates of expected repeated-measures outcomes under the op-
timal decision rule and specific embedded DTRs respectively. The optimal trajectory
is estimated using mQ-GEE with equally weighted outcomes. The DTR-specific tra-
jectories are estimated using Q-GEE with stagewise QIC-based variable selection by
plugging in a set of deterministic values for (A1 = a1, A2 = a2).
Figure 2.6: Estimated optimal trajectory versus marginal DTR-specific trajectories.
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Figure 2.7 shows the empirical distributions of estimated heterogeneous treatment
effects across all time points of measurement. For stage 1 intervention, it is not surprising
to see that early intervention has more positive effects on early measurements (self-
monitoring and follow-up 1) and late intervention has more positive effects on late
measurement (follow-up 2). The result for stage 2 intervention is consistent with the
investigator’s findings (Patrick et al., in press) that the automated email was more
effective in reducing frequency of binge drinking for heavy drinkers as compared to
online health coach.
Figure 2.7: Distribution of estimated heterogeneous causal effects using modified Q-
learning with GEE. The first panel is estimated based on stage 1 Q-function, with each
boxplot representing the distribution of the contrast between Early and Late over time.
Since negative treatment effects are preferred, an average treatment effect (indicated by
a black square) below 0 shows that Early wins. The second panel is estimated based
on stage 2 Q-function, with each boxplot representing the distribution of the contrast
between Coach and Email over time. Similarly, an average treatment effect (indicated
by a black square) below 0 shows that Coach wins.
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2.6 Discussion
We developed an implementation of Q-learning on stagewise repeated-measures out-
comes using generalized estimating equations. To apply the proposed method, inves-
tigators have the flexibility to choose science-driven weights for the repeated-measures
outcomes. For implementing GEE, we recommend specifying unstructured working
correlation, because in conventional SMARTs, participants are followed a considerably
small number of times before the next stage of re-randomization or the end of study,
and sample size is comparatively large. Furthermore, by using a saturated marginal
model with time-varying coefficients, the impact of choosing a wrong working correla-
tion is negligible. We also explored the performance of the proposed method in terms of
rule identification and the consistency and efficiency of estimating heterogeneous causal
effects. The performance of regression-based Q-learning depends heavily on correct
specification of models at all stages. The modified version of Q-learning with GEE
mitigates the problem by incorporating the residual from observed outcomes at subse-
quent stages into the pseudo-outcome at previous stages. This thesis focuses only on
point estimation of the optimal trajectory. Inference under nonregularity conditions,
where the weighted stage 2 treatment effect equals to 0, can be a complex problem that
needs further research. Moreover, future work needs to be done to extend the proposed
method for discrete outcomes, e.g., dichotomous responses which many investigators
care about in clinical trials.
Chapter 3
On the Model Misspecification in
Q-learning with Treatment Effect
Heterogeneity
3.1 Literature Review
Q-learning with linear regression (Murphy, 2005b; Nahum-Shani et al., 2012) is a widely
used backward induction algorithm to identify the optimal DTR due to its ease of
implementation. At each stage of randomization, Q-learning specifies a Q-function, a
parametric model of the expected pseudo-outcomes conditional on past history, where
the pseudo-outcomes are the potential outcomes assuming that the optimal interventions
are followed thereafter. Typically in practice, one specifies the Q-function as a linear
model, which consists of a main effect model and a treatment effect model, and the
model parameters are usually estimated using least squares estimation. The main effect
component characterizes the variation in the outcome that is explained by pre-treatment
covariates, whereas the treatment effect component characterizes the average effect of
the observed treatment allowing for variation with pre-treatment covariates.
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Decision making at a single stage, for example, using data from a randomized con-
trolled trial, does not depend on the main effect model, as the treatment effect model
fully defines the estimated optimal rule. However, this is not the case for backward
induction over multiple stages. The performance of Q-learning is susceptible to model
misspecification of the main effect model. Heterogeneous treatment effects at an earlier
stage on a final outcome are in fact part of the main effects at later stages (either the
earlier treatment-covariate interaction or an intermediate measurement which depends
on prior treatement). It is reasonable to conjecture that omitting them at later stages
would result in biased estimation of the treatment effects at early stages. This is an
example of informative residual bias in optimizing over multiple stages.
Additionally, heterogeneous treatment effects at a later stage result in biased estima-
tion if linear models are used in earlier stages as the optimization operation necessarily
makes the linearity misspecified. Though the treatment effect model of a Q-function
is assumed to be correctly specified with no unmeasured confounders, a nonlinear re-
lationship between the predictors and the pseudo-outcome, which usually involves an
absolute value function of the estimated treatment effects, arises inevitably when the
estimated treatment effects at late stages are heterogeneous. This problem was studied
comprehensively by Laber et al. (2014).
Both types of misspecification described above result in a nonnegligible bias in the
prediction of stage 1 optimal rules, and have been addressed with carefully constructed
methods. Existing methods that deal with residual bias are modified Q-learning (Huang
et al., 2015), A-learning (Schulte et al., 2014) and robust Q-learning (Ertefaie et al.,
2021). A-learning takes a propensity score approach and allows for flexible modeling
of the main effects. Robust Q-learning as well takes a propensity score approach, but
obviates the need to specify the main effect model. However, nonparametric methods
are usually used to estimate the main effects in A-learning and the expected outcome
in robust Q-learning. Nonparametric methods work ideally for nonlinearity between
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outcomes and covariates, but are less straightforward when implementation and inter-
pretation come into consideration. Moreover, model checking and residual diagnostics
for Q-learning with linear regression can be easily performed using standard approaches
(Henderson et al., 2010; Chakraborty and Moodie, 2013). Therefore, we advocate the
use of modified Q-learning, a parametric approach that takes account of stage 2 residu-
als, for dealing with misspecification of the main effect model. For the treatment effect
model, Laber et al. (2014) proposed an interactive model building of Q-learning to cor-
rect the bias caused by misspecified linearity between pseudo-outcome and predictors.
The above-mentioned methods work well for one specific type of misspecification, but
fail to consider the coexistence of misspecifications as a result of heterogeneous treatment
effects. This chapter starts with an introduction of the data structure and a further
elaboration on the importance of the problem using the M-bridge study as an example.
We then discuss the integrative impact of late-stage unadjusted residuals and early-
stage nonlinearity on the prediction of optimal rules, with mathematical formulation and
proof in Section 3.4 to help understand the statistical aspects of the problem. We then
propose to build interactive models into modified parametric Q-learning with Murphy’s
regret function in Section 3.5. Simulations are performed to show the robustness of
our proposed algorithm. Finally, we demonstrate its application on SMARTs with
embedded tailoring using the M-bridge data.
3.2 Framework
3.2.1 Data Example
The data example we use to illustrate the problem omits the repeated-measures outcome
in the M-bridge design. As shown in Figure 3.1, the outcomes of interest, binge drinking
(primary outcome) and negative drinking-related consequences (secondary outcome),
were measured at the end of Semester 1 for all students. The target outcomes for
analysis in this section are the maximum number of drinks and the total number of
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Figure 3.1: The M-bridge study design and data structure. R indicates a random-
ization stage with arrows pointing to available treatment options, and A indicates an
assessment of outcomes. Note that this design only considers a final outcome measured
at the end of the treatment course.
drinking-related consequences, both of which are continuous.
The scientific question is to predict, for each potential subject, the embedded DTR
that optimizes two different final outcomes at the end of the treatment course: minimizes
the maximum number of drinks consumed within a 24-hour period, or the total number
of alcohol-related consequences in the past 30 days, which was measured using 24 items
from the Brief Young Adult Alcohol Consequences Questionnaire (B-YAACQ). In other
words, our aim is (1) to estimate the stage 1 intervention, i.e., if a student should receive
PNF+SM early or late, conditional on his/her baseline characteristics, and then (2) to
estimate stage 2 strategy, if the student should receive an automated email or online
health coaching if he/she is a heavy drinker but continue self-monitoring if he/she is
not a heavy drinker, so that the combined regime optimizes the potential outcome.
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In the M-bridge study, the investigators hypothesize that pre-college alcohol use
norms and pre-college intentions for college drinking are treatment effect moderators.
These baseline variables might moderate both stage 1 and stage 2 treatment effects,
and inappropriate adjustment is likely to occur in the Q-functions at both stages as a
result of heterogeneous treatment effects. Details will be discussed in Section 3.4.
3.2.2 Data Structure
As in the M-bridge study, we assume a two-stage setting, although the following could
be generalized to multiple decision points. Suppose that the data collected from a
SMART are represented by a sequence of independently and identically distributed
random variables (Z1, A1, Z2, A2, Y ), where Z1 is the set of baseline covariates and
potential moderators measured prior to stage 1 randomization, Z2 is the set of time-
varying covariates and tailoring variables measured after stage 1 and before stage 2
randomization, Ak ∈ Ak, k = 1, 2, is the treatment that the participant receives at stage
k, with Ak being the set of all possible treatments, and Y is the outcome measured after
treatment stages, with smaller values preferred.
In the M-bridge study, A1 = {−1, 1}, where A1 = 1 represents early intervention
and A1 = −1 represents late intervention, and A2 = {−1, 1}, where A2 = 1 represents
online health coach and A2 = −1 represents automated email. Z1 includes baseline
information on subject characteristics (gender, race, intention to pledge to a sorority
or fraternity [i.e., ”Greek”], and indicator whether parent has a significant drinking
problem), pre-college drinking norms and intention for college drinking, and pre-college
drinking habits. Z2 includes solely the embedded tailoring variable, i.e., the flag of
heavy drinkers. Y can be either the maximum number of drinks consumed within a
24-hour period or the total number of negative alcohol-related consequences in the past
30 days, and separate analyses should be done for each outcome. Let H1 = Z1 and
H2 = (Z1, A1, Z2) denote the covariate and treatment history up to the stage 1 and
stage 2 randomization respectively.
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3.2.3 Q-learning
We describe the algorithm of Q-learning with linear regression to answer the scientific
question. Starting from stage 2, the Q-function is specified as







where X20 and X21 denote the vectors formed by elements in H2 that represent the
predictors in stage 2 main effect model and treatment effect model respectively. The















using ordinary least squares.
For the preceding stage (i.e., stage 1), the Q-function is specified as















where X10 and X11 denote the vectors formed by elements in H1 that represent the
predictors in stage 1 main effect model and treatment effect model respectively. The















using ordinary least squares.











Hj , Aj = aj ; β̂j00, β̂j
)
for j = 1, 2. (3.3)
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3.3 Unmeasured Variables
3.3.1 Misspecification of Stage 2 Main Effects
To understand the problem thoroughly, we first focus on model misspecification in the
presence of an important variable prior to stage 2 randomization which is not measured
by design or omitted in the data analysis. Huang et al. (2015) argues that an unmeasured
variable causes bias in the estimation of stage 1 optimal rules and model parameters.
We briefly outline the argument here. Let V20 denote a vector of unmeasured covariates
at stage 2 that are independent of A2. We use uppercase to denote random variables
and lowercase to denote a realization of the corresponding random variable.
Suppose Y conditional on all the covariates, measured or unmeasured, has mean







and variance Var(Y |H2, A2,V20) = σ22.
3.3.2 Estimation Bias
The proof of the theorems can be found in the supplementary materials.
Theorem 3.3.1 (Matrix Version of the Omitted Variable Bias Theorem). Suppose
that the true regression model for Y is Y = ψ0 + X
Tψ1 + V
Tγ + ε, where X is a
random vector formed by measured covariates, V is formed by unmeasured covariates,




are thus estimated via the misspecified model y = β0 + x
Tβ1 + ε
∗, where y and x are
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denote the full predictor vector and assume that the













The first element of B corresponds to the bias associated with the intercept term and
the second element of B corresponds to the bias associated with the covariate effects.
The existence of bias in the estimation of covariate effects is then characterized by the








and Cov(A2,V20) = 0
T for SMARTs due to sequential randomization.
Theorem 3.3.2 (Bias of Stage 2 Treatment Effect Estimators). Assume that V20 is a
vector of unmeasured covariates that are independent of A2 and Cov(X2) is invertible.
The estimators of stage 2 heterogeneous treatment effects are unbiased if and only if at
least one of the following conditions is satisfied:
• E(A2) = 0;
• V20 is correlated with neither X20 nor X21.
Theorem 3.3.3 (Bias of Stage 2 Main Effect Estimators). Assume that V20 is a vector
of unmeasured covariates that are independent of A2 and E(A2) = 0. Suppose that V20
is correlated with X20 and Cov(X2) is invertible. Then the estimators of stage 2 main
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effects are biased and the bias is B′γ20, where
B′ =




Theorem 3.3.2 shows the importance of balancing sample size in the randomization
arms. With unbalanced designs, it is possible to bias the estimation of stage 2 treatment
effects. However, this is not the case we consider in this thesis. In the M-bridge study,
heavy-drinkers were re-randomized to A2 = 1 and A2 = −1 with equal probabilities,
i.e., E(A2) = 0, so no bias would be induced in the identification of stage 2 optimal
rules. Theorem 3.3.3 shows that the estimators of stage 2 main effects, however, can be
biased if the unmeasured variable V20 is correlated with X20.
3.3.3 A Special Case: Omission of Stage 1 Heterogeneous Treatment
Effects
Now we understand how omission of an unmeasured variable causes bias in the estima-
tion in the main effect and treatment effect models. As a special case, omitted stage
1 heterogeneous treatment effects in the stage 2 main effect model may similarly cause
a loss in the power to correctly predict stage 1 optimal rules. Investigators usually do
not care much about the adjustment for stage 1 treatment effects in the stage 2 model
as only the (heterogeneous) treatment effects of stage 2 intervention would determine
the stage 2 optimal rules. Thus, Q-learning with linear regression is often implemented
using a linear predictor function such that the same design matrix is used for both the
main effect and treatment effect models. Moreover, three way interactions are rarely
included in the stage 2 treatment model, so X21 often does not include interactions
between A1 and baseline covariates. However, doing so may result in a bias for stage 1
estimation.
As a special case of Equation (3.4), suppose Y follows an independent and identical
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distribution with mean











does not include the interaction between base-





and the unmeasured variables A1X11 in Equation (3.7), the bias of
stage 2 main effect estimators is
B′s =










Even if E(A1) = 0, B′s is a nonzero vector.
Thus, we have shown that wrongly omitting stage 1 heterogeneous treatment effects
results in biased estimation of stage 2 main effects. This is the case we would like to
address in this chapter. Furthermore, investigators should be alert to this issue in the
use of Q-learning software. qLearn (Xin et al., 2012) allows for different and explicit
specifications of the main effect and treatment effect model, but it is less straightforward
in qlaci (Ertefaie et al., 2014) and iqLearn (Linn et al., 2015).
3.4 Model Misspecification with Treatment Effect Hetero-
geneity
In this section, the integrated impact of the two sources of model misspecification caused
by heterogeneous treatment effects is formulated mathematically and discussed in detail.
Following the setting in Section 3.3.3, suppose Y follows an independent and identical
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distribution with mean







where X20 = X21 does not include the interaction between baseline covariates and stage
1 treatment. Assume E(A1) = E(A2) = 0. In the backward induction setting, stage 1
optimization is contingent on compliance with the optimal rule at stage 2, so the true
optimal pseudo-outcome at stage 1 is
Y opt = E
(
Y
∣∣∣H2, A2 = dopt2 ) = ψ200 + xT20ψ201 + a1xT11γ20 − ∣∣ψ210 + xT21ψ211∣∣ ,
where dopt2 is the optimal decision rule at stage 2 and




























, and rewrite Y opt as
Y opt ≡ x̃T20ψ20 + a1xT11γ20 −
∣∣x̃T21ψ21∣∣ . (3.10)
−
∣∣∣X̃T21ψ21∣∣∣ represents the stage 2 optimal treatment effect, and is a non-smooth function
of ψ21. Nonregularity of stage 1 parameters due to the non-smooth function −
∣∣∣X̃T21ψ21∣∣∣
has been extensively studied in literature (Robins, 2004; Chakraborty et al., 2010). In








The estimator of Y opt is





















. For large samples, β̂21 is a
consistent estimator of ψ21. Under assumption (3.11),
∣∣∣x̃T21β̂21∣∣∣ is also a consistent
estimator of
∣∣x̃T21ψ21∣∣ by the continuous mapping theorem. However, ∣∣∣x̃T21β̂21∣∣∣ is a
biased estimator of
∣∣x̃T21ψ21∣∣ as ∣∣x̃T21ψ21∣∣ 6= 0.
Normality and linearity are usually assumed for the conditional distribution of stage
2 effects on stage 1 covariates, but in stage 1 estimation, bias can still be induced
by the absolute value function
∣∣x̃T21ψ21∣∣. Q-learning requires the causal assumption of
no unmeasured confounders to be satisfied in order to obtain unbiased estimators of
treatment effects, i.e., the treatment model at each stage is correctly specified. Thus,
the bias discussed here does not result from misspecification of the treatment model,
but intrinsically from the misspecified linear relationship between the pseudo-outcome
and stage 1 covariates, as a result of the optimization operation. The detailed proof of
the nonlinear relationship can be found in the supplementary materials of Interactive
Model Building for Q-learning (Laber et al., 2014), and the main idea is built upon
Theorem 3.4.1.





















Now we derive an expression for stage 1 bias from model misspecification asso-









≡ X̃T10β10 + a1X̃T11β11. The values of the stage 1
parameters can be obtained as





∣∣∣X̃T21β21∣∣∣− X̃T10β10 −A1X̃T11β11}2] .













matrix for stage 1 estimation and is of full column rank, and Y opt is the outcome


















































(∣∣x̃T21ψ21∣∣∣∣ x̃1, a1)− x̃T1 E{(X̃T1 X̃1)−1 X̃T1 E(∣∣∣X̃21β̂21∣∣∣∣∣∣H1, A1)}] , (B)
where B′s is the expression in Equation (3.9). Bias (A) is induced by the omission of
stage 1 heterogeneous treatment effects in the stage 2 main effect model, and bias (B)
is induced by the false assumption of linearity between the absolute value of stage 2
heterogeneous treatment effects and stage 1 predictors.
3.5 The Proposed Method
3.5.1 Modified Interactive Q-learning
Interactive Q-learning (Laber et al., 2014) was proposed to address the misspecified
linearity in stage 1 estimation by separately regressing stage 2 main effects on stage 1
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predictors and estimating the conditional distribution of stage 2 treatment effects con-
ditional on stage 1 predictors, and then combining the former and the expected absolute
value of the latter to get the estimated stage 1 Q-function. To address both types of
bias concomitantly, our proposed method follows the virtue of interactive Q-learning
and modifies the main effect portion of the algorithm to account for any informative
residuals from stage 2 estimation.
The modified interactive Q-learning (mIQ) algorithm comprises the following steps:
(mIQ-1) Regress Y on H2, A2 based on stage 2 Q-function





to obtain the ordinary least squares estimators β̂20, β̂21;











denoted by m̂(H1, A1);
(mIQ-4) Estimate the conditional distribution g
(
X̃T21ψ21
∣∣∣H1, A1), denoted by ĝ(·|H1, A1):
If g is a conditional normal density with constant variance, i.e.,
X̃T21ψ21
∣∣∣H1, A1 ∼ N(µ(H1, A1), σ2),
then regress x̃T21β̂21 on H1, A1 to obtain the estimators µ̂(H1, A1) and σ̂;
47
(mIQ-5) Obtain the estimator of E
(
Y opt
∣∣H1, A1) = E(X̃T20ψ20 − ∣∣∣X̃T21ψ21∣∣∣∣∣∣H1, A1)
by combining the above estimators:
Q̂1(H1, A1) = m̂(H1, A1)−
∫
|z|ĝ(z|H1, A1)dz,
where the integral can be easily calculated for a location-scale distribution g
using Theorem 3.4.1;
(mIQ-6) Predict the stage 1 optimal rule for a subject with baseline covariates h1:
d̂opt1 = arg min
a1∈{−1,1}
Q̂1(H1 = h1, A1 = a1).
Step (mIQ-3) incorporates any stage 2 residual remainder from misspecification of the




∣∣∣H1, A1). The assumption of g in Step (mIQ-4) can
be loosened and empirical methods can be applied.
3.5.2 Small Sample Properties of the Proposed Estimator
The pseudo-outcome in the stage 1 estimation, Y opt = E
(
Y
∣∣∣H2, A2 = dopt2 (H2)) can
be a counterfactual outcome. If dopt2 = a2, then the expression represents the expected
observed outcome at stage 2; if dopt2 6= a2, then it represents the expected counterfactual
outcome. With the observation that























































(∣∣∣X̃T21ψ21∣∣∣∣∣∣H1, A1)}− E(∣∣∣X̃T21ψ21∣∣∣∣∣∣H1, A1)] (3.14)
Therefore, unbiased estimation of stage 1 Q-function requires that (1) stage 1 model
is correctly specified so that the linearity between Y and stage 1 predictors is valid
(shown by Formula (3.13)), and (2) the assumption of normality of the underlying
distribution g is true so that the conditional distribution of stage 2 treatment effects
on stage 1 predictors is consistently estimated (shown by Formula (3.14)). Laber et al.
(2014) proposed additional nonparametric modeling of g using empirical methods, which
helps to increase the modeling flexibility of this algorithm.
3.6 Simulation
3.6.1 Preliminaries
We conduct a simulation study to show the predictive performance of the proposed
algorithm in the context of small samples. We start the discussion with a description
of the data generative mechanism. Assume a sequence of observations from a SMART
study is (Z1i, A1i, Z2i, A2i, Yi), i = 1, . . . , n, where Z1i
i.i.d.∼ N(−2, 1), Z2i = Z1i + φi
and φi
i.i.d.∼ N(0, 4), A1i and A2i both follow an i.i.d. Rademacher distribution, so
A1i + 1
2
i.i.d.∼ Bernoulli(0.5) and A2i + 1
2
i.i.d.∼ Bernoulli(0.5). There is no embedded








i.i.d.∼ N(0, 1) and small values of Yi are preferred. The preliminary study
considers three scenarios for the stage 2 main effects and two scenarios for the stage 2
treatment effects:
Stage 1 treatment effects Stage 2 treatment effects
X̃T20,iψ20 = 3− Z1i + 0.1A1i − 0.1Z2i + c1Vi X̃T21,iψ21 = −6 + α1Z1i + 5A1i + α2Z2i
Homogeneous Homogeneous
• Vi uncorrelated with H2i: Vi ∼ N(−1, 1) • α1 = 0, α2 = 0
• Vi correlated with H2i: Vi ∼ N(2Z1iZ2i, 1)
Heterogeneous Heterogeneous
• Vi = Z1iA1i • α1 = −4, α2 = −0.2
Table 3.1: Specifications of stage 2 main effect and treatment effect model in the data
generative mechanism.
For a data generative mechanism that utilizes one specification of both X̃T20,iψ20
and X̃T21,iψ21, we generate training datasets of sample size n, and a test dataset of N
subjects with potential outcomes under the four treatment regimes for each subject.
Hence, the true optimal rules, dopt1 and d
opt
2 , are known for each subject in the test
dataset by minimizing the potential outcomes over all treatment regimes. The training
datasets are then used to estimate the linear models specified at each stage, and the







subject in the test dataset. In our framework, Z2 is defined as the set of stage 2 time-
varying covariates and tailoring variables. Note that in this setting, Z2 does not vary
with A1 in predicting d̂
opt
2 . Thus, we do not need to worry about the change in Z2 with







Preliminary results (Table 3.2) show that omission of stage 1 heterogeneous treat-
ment effects in stage 2 main effect model causes significant bias in stage 1 rule identifica-
tion. Omission of a variable that is uncorrelated with other stage 2 main predictors does
not cause bias, but if the omitted variable is correlated with other main predictors, then
bias is generated. Interactive Q-learning indeed does not tackle this problem and may
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have a slightly worse performance than standard Q-learning in this scenario. Onwards,
we focus on the performance of our proposed method in the case where both stage 1 and
stage 2 treatment effects are heterogeneous, i.e., Vi = Z1iA1i and α1 = −4, α2 = −0.2.
c1 = 0 c1 = 1 c1 = 2 c1 = 3 c1 = 4
Q-learning
Vi ∼ N(−1, 1) 1 1 1 1 1
Vi ∼ N(2Z1iZ2i, 1) 1 1 1 0.992 0.981
Vi = Z1iA1i 1 1 0.965 0.707 0.543
Interactive Q-learning
Vi ∼ N(−1, 1) 1 1 1 1 1
Vi ∼ N(2Z1iZ2i, 1) 1 1 0.998 0.990 0.976
Vi = Z1iA1i 1 1 0.965 0.707 0.541
Table 3.2: Percentage of correctly identified stage 1 optimal rules when stage 2 treatment
effects are homogeneous across subjects (α1 = α2 = 0), prediction using standard Q-
learning and interactive Q-learning, based on a set of test data (N = 10000) and 100
simulations of training data (n = 250).
3.6.2 Results
We compare the proposed method (mIQ) with standard Q-learning (sQ), modified Q-
learning (mQ; Huang et al. (2015)), and interactive Q-learning (IQ; Laber et al. (2014)).
c1 c2 sQ mQ IQ mIQ
0.0
1.0 0.963 0.963 0.969 0.969
2.0 0.969 0.970 0.976 0.976
3.0 0.969 0.969 0.973 0.973
2.0
1.0 0.869 0.965 0.910 0.985
2.0 0.900 0.964 0.947 0.981
3.0 0.921 0.966 0.963 0.979
4.0
1.0 0.893 0.972 0.892 0.986
2.0 0.871 0.966 0.910 0.985
3.0 0.883 0.963 0.934 0.981
Table 3.3: Percentage of correctly identified stage 1 optimal rules when stage 2 treatment
effects are heterogeneous across subjects (α1 = −4, α2 = −0.2), based on a set of test
data (N = 10000) and 100 simulations of training data (n = 250).
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Table 3.3 summarizes the probabilities of correctly identifying stage 1 optimal rules
based on the four methods considered, and mIQ has the highest accuracy across all
scenarios. The results show that the modified interactive Q-learning algorithm corrects
for potential bias generated from both stage 1 and stage 2 heterogeneous treatment effects.
Figure 3.2: Probability of correctly identifying stage 1 optimal rules as a function of c2
for c1 = 0, 2, 4.
Figure 3.2 plots the trend with varied c2 at finer intervals for the three values of
c1. If stage 1 treatment effects are homogeneous (c1 = 0), then the four methods work
similarly, and modified interactive Q-learning performs exactly the same as interactive
Q-learning. If stage 1 treatment effects are highly heterogeneous (c1 = 4), then modified
interactive outperforms all other methods, and there is a substantial difference in the
probability of correctly identifying stage 1 optimal rules between modified Q-learning
and modified interactive Q-learning. It further stresses the importance of building
interactive models into modified Q-learning.
52
3.7 Data Analysis
We use the M-bridge data (n = 591) to illustrate the application of the proposed method
on SMARTs with embedded tailoring. Figure 3.1 shows the design of M-bridge for this
analysis. Our aim is to identify the personalized optimal DTR for each subject in the
dataset, which minimizes binge drinking (primary outcome, 490 subjects with complete
data on the maximum number of drinks within a 24-hour period at baseline and follow-
up), and negative drinking-related consequences (secondary outcome, 496 subjects with
complete data on the total number of drinking-related consequences in the past 30
days at baseline and follow-up). We perform the data analysis separately for these two
outcomes.
Stage 2 model uses as covariates baseline characteristics, including gender, race,
intention to pledge Greek, indicator whether parent has a significant drinking problem,
pre-college drinking norms and intention for college drinking, and pre-college drinking
habits, and the interaction between stage 2 intervention and baseline characteristics.
Stage 1 model uses as covariates baseline characteristics and their interaction with
stage 1 intervention. A summary of the covariates and outcomes used in the model is
presented in Table 3.4.
Table 3.4: Summary statistics of subject characteristics by initial randomization (stage
1 intervention). Discrete variables are summarized by counts; continuous variables are
summarized by mean (SD).
Early Intervention Late Intervention Overall
(n1 = 295) (n2 = 296) (n = 591)
Demographics
Gender
Male 115 104 219
Female 180 192 372
Continued on next page
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Table 3.4 – Continued from previous page
Early Intervention Late Intervention Overall
(n1 = 295) (n2 = 296) (n = 591)
Race
White 229 222 451
Nonwhite 66 74 140
Intention to pledge Greek
Yes 34 33 67
No or Undecided 261 263 524
Parent drinking problem1
Clearly Yes 46 31 77
Clearly No or Not Sure 247 264 511
Pre-college drinking norms
Percent of students drink (%)2 53.0 (19.9) 52.4 (21.1) 52.7 (20.5)
Number of drinks per week3 5.65 (8.35) 5.24 (6.01) 5.45 (7.27)
Max number of drinks in a row4 5.62 (3.32) 5.35 (3.55) 5.48 (3.44)
Percent of students binge (%)5 22.4 (17.5) 22.9 (17.8) 22.7 (17.7)
Intention for college drinking
Drinking frequency per month 6 2.37 (2.70) 2.29 (2.80) 2.33 (2.75)
Number of drinks7 1.98 (1.77) 2.14 (1.91) 2.06 (1.84)
Drunk frequency per month8 1.39 (1.98) 1.43 (2.28) 1.41 (2.13)
Pre-college drinking habits
Number of days 9 2.05 (3.09) 2.03 (3.25) 2.04 (3.17)
Continued on next page
1Indicator whether the subject’s mother or father has had a significant drinking problem that did or
should have led to treatment
2Norm on the percentage of UMN first-year students who used alcohol during the last 30 days
3Norm on the number of alcoholic drinks a typical UMN first-year student consumed during an
average week
4Norm on the largest number of drinks a typical college student had in a row during the last two
weeks
5Norm on the percentage of UMN first-year students had five or more drinks in a sitting during the
last two weeks
6Intent frequency of drinking alcohol in the next 6 months
7Intent number of drinks on a typical occasion
8Intent frequency of consuming enough alcohol to feel drunk or intoxicated in the next 6 months
9Number of days using alcohol during the last 30 days
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Table 3.4 – Continued from previous page
Early Intervention Late Intervention Overall
(n1 = 295) (n2 = 296) (n = 591)
Average number of drinks10 1.83 (2.37) 1.75 (2.35) 1.79 (2.36)
Re-randomization/Stage 2
Heavy drinker 75 83 158
Non-heavy drinker 220 213 433
Stage 2 intervention
Continued self-monitoring11 220 213 433
Online health coach 37 43 80
Automated email 38 40 78
max_drinks (n = 490) byaacq (n = 496)
Baseline End of Semester 1 Baseline End of Semester 1
Early/Email 5.83 (3.17) 7.20 (3.22) 2.89 (3.06) 5.06 (4.04)
Early/Coach 4.94 (3.08) 7.15 (2.68) 2.97 (2.26) 5.18 (4.77)
Early/- 1.72 (2.88) 2.37 (2.90) 0.92 (2.15) 1.32 (2.43)
Late/Email 3.78 (2.66) 6.03 (2.86) 2.79 (2.46) 4.15 (4.06)
Late/Coach 6.22 (4.81) 8.03 (3.69) 3.28 (3.43) 5.22 (4.18)
Late/- 1.20 (2.10) 2.34 (2.87) 0.57 (1.52) 1.13 (2.05)
Overall 2.55 (3.38) 3.72 (3.68) 1.39 (2.42) 2.28 (3.40)
Table 3.5: Summary statistics of outcomes by DTR. Continuous variables are sum-
marized by mean (SD). “Early/-” and “Late/-” indicate the subgroup of non-heavy
drinkers who were not re-randomized to stage 2 interventions.
Table 3.5 summarizes the outcomes by observed DTRs. For the primary outcome
(max_drinks), stage 2 model utilizes data on the 140 heavy drinkers with complete data,
who were flagged based on the frequency of binge and high-intensity drinking during
10Number of drinks had on a typical day when drinking alcohol during the last 30 days
11Subjects who were identified as non-heavy drinkers were not randomized at stage 2 and continued
self-monitoring
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the self-monitoring period at stage 1, whereas stage 1 model utilizes data on the 490
enrolled students with complete data. Implementing modified interactive Q-learning,
181 (37.0%) subjects are predicted to benefit most from receiving late intervention at
stage 1 based on their baseline characteristics, and 90 (64.3%) are predicted to benefit
most from receiving automated email at stage 2 had they received the predicted stage
1 optimal treatment.
For the secondary outcome (byaacq), stage 2 model utilizes data on the 142 heavy
drinkers with complete data, whereas stage 1 model utilizes data on the 496 enrolled stu-
dents with complete data. Implementing modified interactive Q-learning, 229 (46.2%)
subjects are predicted to benefit most from receiving late intervention at stage 1 based
on their baseline characteristics, and 77 (54.2%) are predicted to benefit most from
receiving automated email at stage 2 had they received the predicted stage 1 optimal
treatment.
Figure 3.3: Residual diagnostics for (a) the parsimonious model (b) the saturated model:
an illustration using the primary outcome max_drinks.
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The proposed method requires that any missingness in the outcome measurements
is not informative. M-bridge might not be a perfect example of informative residuals,
because the interaction between A1 and Z1 does not have a significantly impact on
the outcome. Figure 3.3 shows that, for the primary outcome, residual diagnostics of
the parsimonious model do not differ much from those of the saturated model. How-
ever, modified interactive Q-learning still helps as the huge amount of baseline covari-
ates might cause the problem of overfitting. Nevertheless, we anticipate that modified
interactive Q-learning performs similarly as interactive Q-learning in this case. The
comparison is shown in the supplementary materials.
3.8 Discussion
This chapter attempts to understand the bias caused by misspecification of the main
effect model in the implementation of Q-learning, specifically, omitting an unmeasured
variable, and confirms the existence of bias when the unmeasured variable is correlated
with the observed predictors (especially stage 1 treatment). As stage 1 heterogeneous
treatment effects are usually neglected in the stage 2 main effect model and might be
a significant predictor, we then modify the Q-learning algorithm to account for the
unexplained residuals. This modification is then built into the interactive Q-learning,
which corrects the bias generated by stage 2 heterogeneous treatment effects and the
optimization operation, to improve the overall performance where both stage 1 and 2
treatment effects are heterogeneous. The proposed method and the simulation results
assume that the two randomization arms at each stage are equally assigned. If the
randomization scheme has an unbalanced allocation ratio, then the estimators of stage
2 treatment effects would be biased in the presence of an unmeasured variable. Future
work and exploration of Q-learning in this context would be merited.
Chapter 4
A Generalization to Dichotomous
Outcomes
4.1 Background
Clinical investigators are commonly interested in dichotomous endpoints as the outcome
can be easily differentiated across subjects, especially when there is a gold standard
cut-off point with a clear justification. To optimize DTRs for dichotomous outcomes,
one common method is Q-learning with logistic or probit regression. This chapter
aims to address the informative residuals due to misspecification of late-stage main
effect model for dichotomous outcomes. Methods that posit more flexibility in modeling
Q-functions include generalized additive model (Moodie et al., 2014), which allows a
nonlinear relationship between outcome and predictors, and Bayesian machine learning
(Murray et al., 2018), which obviates the nonregularity problem in Q-learning and
utilizes a probit Bayesian additive regression trees model for the dichotomous outcomes.
Despite the fact that these methods perform well in many circumstances, they are not
developed for the purpose of dealing with informative residuals. For Q-learning with
linear regression, a modification with Murphy’s regret function (Huang et al., 2015) was
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proposed to correct for the informative residuals. However, a difficulty arises if modified
Q-learning is used for dichotomous outcomes, as the probability of a success is linked
to the linear combination of predictors using a non-identity function.
One solution to this problem would be imposing monotonicity of preferences to early-
stage pseudo-outcomes. If a subject was observed to receive an optimal treatment, then
the corresponding pseudo-outcome would be the observed outcome. If a subject was
observed to receive a suboptimal treatment and responded with the desirable outcome,
then they must have responded, had they received the optimal treatment. However,
there is no restriction that we could impose on potential pseudo-outcomes for subjects
who received the suboptimal treatment and responded with the undesirable outcome.
These subjects could possibly respond with desirable or undesirable outcomes had they
received the optimal treatment. Therefore, this approach results in a loss of information.
We present Q-learning with probit regression and the proposed modification in Sec-
tion 4.2. A simulation study is performed in Section 4.3 to investigate the potential
improvement of the modification. The data example in Section 3.2.1 with a different
set of outcomes is used to illustrate the methods, and the results are summarized in
Section 4.4. Moreover, probit regression is equivalent to a latent variable model where
the underlying continuous variable is modeled explicitly. In Section 4.5, we discuss the
feasibility of using latent variable modeling to correctly estimate the underlying continu-
ous variable, and propose a novel algorithm which samples surrogates from a truncated
normal distribution as estimates of the latent variable and adds back the Murphy’s
regret function to generate early-stage pseudo-outcomes.
4.2 Methods
Suppose that the data collected from a SMART are represented by a sequence of inde-
pendently and identically distributed random variables (Z1, A1, Z2, A2, Y ), where Z1 is
the set of baseline covariates and moderators measured prior to stage 1 randomization,
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Z2 is the set of time-varying covariates and potential tailoring variables measured be-
tween stage 1 and stage 2 randomizations, Ak ∈ Ak, k = 1, 2, is the treatment at stage
k, with Ak being the set of all possible treatments, and Y ∈ (0, 1) is the dichotomous
outcome measured after treatment stages, with Y = 0 preferred.
In the M-bridge study, the investigators are primarily interested in preventing binge
and high-intensity drinking, so whether a student had binge drinking, i.e., the frequency
of binge drinking was greater than 0, would be an outcome of great interest. We hypoth-
esize a scenario where the actual frequency of binge drinking for each college student is
hidden in the data cleaning process, and we only have the information whether the fre-
quency of binge drinking is greater than 0. A value of 0 is preferred for the indicator of
binge drinking. The secondary outcome considered by the investigators is health services
utilization, which is a dichotomous measure of whether students used any health services
over the past three months, including through a healthcare clinic, individual counseling,
group therapy, support groups, self-help resources, or other services/resources. A value
of 1 is preferred for health services utilization.
4.2.1 Q-learning with Probit Regression
One commonly used method to optimize DTRs for binary outcomes in the literature
is Q-learning with logistic regression or probit regression. With the probit link, an
equivalent formulation is to assume that there is a latent variable that is linearly related
to covariates with an error term following a standard normal distribution, and we only
observe the indicator for whether the latent variable is greater than a certain threshold.
The alternative formulation will be discussed in detail in Section 4.5.
Consider the model for Q2(H2, A2) = E(Y |H2, A2) = P(Y = 1|H2, A2):







where Φ is the cumulative distribution function of a standard normal random variable.
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As Φ is a monotonically increasing function, the stage 2 optimal rule is













The pseudo-outcome at stage 1, conditional on stage 2 optimization, is
Ỹ1i = min
a2∈{−1,1}























The stage 1 optimal rule is estimated as











Logit link is sometimes preferred in stage 2 estimation to analyze real data, as it leads
to the estimation of a commonly used association measure, odds ratio, which is easily
interpretable by clinical investigators. Nevertheless, both link functions produce similar
results.
4.2.2 The Proposed Modification
If the main effect model of the stage 2 Q-function in Equation (4.1) is misspecified, i.e.,
an important predictor is omitted, it is difficult to correct for any informative residual
remaining due to the presence of the non-identity link. It is, therefore, tempting to
impose some restrictions directly on stage 1 pseudo-outcome Ỹ1 so that the imputed
distribution over Ỹ1 is closer to reality. Our proposed modification follows the concept
of Murphy’s regret function. At stage 2, if a subject is observed to receive the optimal
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treatment, then the stage 1 pseudo-outcome would be the same as the observed out-
come. On the other hand, if a subject receives the suboptimal treatment, we are not
able to simply add back Murphy’s regret function to obtain the counterfactual outcome
under the optimal treatment. Instead, we impose monotonicity of preferences, i.e., the
treatment which yields a more desirable potential outcome is always preferred. Thus,
the treatment associated with the most desirable potential outcome is optimal. Specif-
ically, if a subject receives the suboptimal treatment and responds with the desirable
outcome Y = 0, then they must have responded with Y = 0 had they received the
optimal treatment. If a subject receives the suboptimal treatment and responds with
the undesirable outcome Y = 1, then we cannot make any correction to stage 1 pseudo-
outcome as it is not guaranteed that the subject would respond desirably enough to
reach Y = 0 counterfactually. The stage 1 pseudo-outcome in this case should still be
drawn from the model in Equation (4.1). If the estimated optimal probability of an
event, min
a2∈{−1,1}
P̂(Y = 1|H2, A2 = a2), is greater than 0.5, then we assign the stage 1
pseudo-outcome as 1; otherwise we assign the stage 1 pseudo-outcome as 0. Thus, the
modified pseudo-outcome at stage 1, conditional on stage 2 optimization, is










































H2i, A2i = a2; β̂20, β̂21
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Different from Q-learning with probit regression, where we obtain stage 1 estima-
tors directly using least squares estimation, stage 1 estimators in the modified algo-








. The stage 1 optimal rule is estimated as













The definition of Ỹ m1i in Equation (4.3) has a piece of information missing: if a subject
receives a suboptimal treatment and responds with the undesirable outcome Y = 1,
though we are not able to make any assumption on stage 1 pseudo-outcome, the un-
derlying continuous variable should have at most the same value had they received the
optimal treatment. Since the proposed modification does not utilize all the information,
its performance is expected to be compromised. However, the proposed approach has
some potential advantages to release the reliance of Q-learning with probit regression
on the correct specification of stage 2 Q-function.
4.3 Simulation Study
We conduct a simulation study to assess the performance of the proposed modification.
Assume a sequence of data collected from a two-stage SMART study is
(Z1i, A1i, Z2i, A2i, Yi), i = 1, . . . , n,
where Z1i
i.i.d.∼ N(−2, 1), Z2i = Z1i + φi and φi






i.i.d.∼ Bernoulli(0.5). There is no embedded tailoring variable in this design.
Suppose
Yi = 1{3− Z1i + 0.1A1i − 0.1Z2i + γZ1iA1i
+A2i (−9− 6Z1i + 7.5A1i − 0.3Z2i) + εi > 10},
where εi
i.i.d.∼ N(0, σ2). Suppose Yi = 0 is preferred.
A test dataset of N subjects is generated with potential outcomes under the four
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treatment regimes for each subject. The true optimal rules, dopt1 and d
opt
2 , are known
for each subject in the test dataset by minimizing the potential latent outcomes over all
treatment regimes. Hence, the test dataset assumes that monotonicity of preferences
holds. Training datasets of sample size n are simulated 1000 times. The training datasets
are then used to estimate the linear models specified for Q-function at each stage, and







subject in the test dataset.
The datasets are simulated based on varying values of γ and σ, where γ controls
the size of the omitted stage 1 heterogeneous treatment effects, indicating the extent to
which the stage 2 main effect model is misspecified, and σ controls the variance of the
outcome. The results are summarized below.
γ PCI1 PCI2
Q-probit mQ-probit Q-probit mQ-probit
0 0.796 (0.090) 0.591 (0.218) 0.986 (0.000) 0.986 (0.000)
1 0.837 (0.069) 0.760 (0.080) 0.989 (0.000) 0.989 (0.000)
2 0.859 (0.058) 0.814 (0.017) 0.993 (0.003) 0.993 (0.003)
3 0.882 (0.046) 0.856 (0.029) 0.991 (0.015) 0.991 (0.015)
4 0.880 (0.018) 0.908 (0.055) 0.984 (0.036) 0.984 (0.036)
5 0.885 (0.009) 0.932 (0.053) 0.987 (0.047) 0.987 (0.047)
Table 4.1: Percentage of correctly identified optimal rules (mean (SD); σ = 3), pre-
diction using Q-learning with probit regression and modified Q-learning with probit
regression, based on a set of test data (N = 10000) and 1000 simulations of training
data (n = 250).
Table 4.1 summarizes the probability of correctly identifying optimal rules (PCI) at
both stages using (1) Q-learning with probit regression (2) modified Q-learning with
probit regression. The modified algorithm does not necessarily perform better than the
original algorithm for all γ’s. As γ increases, i.e., stage 2 model residuals become more
informative to stage 1 rule estimation, the modified algorithm starts to outperform
the original algorithm. The turnaround, in this simulation, occurs at γ = 4. An
intuitive explanation to the exceptionally bad performance of mQ-probit when there is
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no model misspecification is that, hastily using the observed binary outcome as stage 1
pseudo-outcome, when the estimated stage 2 optimal rule is the same as the observed
treatment, might cause harm as misspecification of stage 2 main effect model can affect
the estimation of stage 2 treatment effect model due to the probit link function.
Figure 4.1: Probability of correctly identifying stage 1 optimal rules as a function of σ
for different values of γ using (1) Q-learning with probit regression, and (2) modified
Q-learning with probit regression.
Figure 4.1 shows that improvement of the proposed modification on correctly iden-
tifying the optimal rules is not consistent across the value of σ. For scenarios where
the proposed modification improves the algorithm performance, PCI has a general de-
creasing trend as σ increases. This drawback, however, is not surprising, because the
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uncertainty of classifying the outcome as desirable or undesirable increases as the un-
derlying latent variable is largely dispersed.
4.4 Data Analysis
We use the M-bridge data (n = 591) to illustrate the application of modified Q-learning
with probit regression on SMARTs with embedded tailoring. We follow the design
illustrated in Section 3.2.1 for this analysis, but analyze a different set of outcomes.
Our aim is to identify the personalized optimal DTR for each subject in the dataset,
which minimizes binge drinking (primary outcome, 495 subjects with complete data on
the frequency of binge drinking during the last 30 days at baseline and follow-up), or
maximizes health services utilization (secondary outcome, 493 subjects with complete
data on if the subject used any health resources or services indicated in the questionnaire
in the last 3 months at baseline and follow-up). We perform data analysis separately
for these two outcomes.
ind_binge (%) hs_util (%)
n Baseline Semester 1 n Baseline Semester 1
Early/Email 36 66.7 88.9 36 72.2 52.8
Early/Coach 33 51.5 93.9 33 60.6 48.5
Early/- 179 16.8 24.6 178 71.3 52.8
Late/Email 33 57.6 75.8 33 81.8 54.5
Late/Coach 40 62.5 92.5 40 70.0 55.0
Late/- 174 12.6 25.9 173 72.8 56.6
Overall 495 27.7 43.2 493 71.8 54.2
Table 4.2: Summary statistics of outcomes by DTR: the percentage of subjects who
had binge drinking, and the percentage of subjects who did not utilize health services.
Higher percentage is undesirable. “Early/-” and “Late/-” indicate the subgroup of non-
heavy drinkers who were not re-randomized to stage 2 interventions, and n denotes the
sample size in each DTR.
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Suppose the hypothetical definition of the indicator for binge drinking (ind_binge)
is that the frequency of binge drinking is nonzero during the last 30 days at the time
of measurement. Thus, ind_binge = 0 is desirable. On the other hand, the indicator
for health services utilization (hs_util) is defined by utilizing one or more type of
health sources or services, including a healthcare clinic, individual counseling, group
therapy, support groups, self-help resources, over the last 3 months. Thus, hs_util = 1
is desirable. Table 4.2 summarizes the percentage of students who experienced the
undesirable outcomes marginally, or for each combination of the stage 1/2 interventions.
Data analysis on SMARTs with embedded tailoring using Q-learning with probit
regression is slightly different from the algorithm in Section 4.2.1 as a result of subgroup
re-randomization. Stage 1 pseudo-outcome needs to be a dichotomous outcome with
values 0/1 as opposed to a continuous outcome on the scale of linear predictors. If the
estimated optimal probability of having an event is greater than 0.5, then the stage 1
pseudo-outcome is assigned value 1; otherwise, it is assigned value 0.
Method n1 Stage 1 Prediction n2 Stage 2 Prediction
d̂opt1 = −1 d̂
opt
1 = 1 d̂
opt




Q-probit 495 294 (59.4%) 201 (40.6%) 142 128 (90.1%) 14 (9.86%)
mQ-probit 495 268 (54.1%) 227 (45.9%) 142 128 (90.1%) 14 (9.86%)
hs_util
Q-probit 493 205 (41.6%) 288 (58.4%) 142 55 (38.7%) 87 (61.3%)
mQ-probit 493 233 (47.3%) 260 (52.7%) 142 55 (38.7%) 87 (61.3%)
Table 4.3: Data analysis results using Q-probit and mQ-probit.
The results in Table 4.3 show that Q-probit generates a more distinctive difference
when predicting if a student would benefit most from receiving stage 1 intervention
early (d̂opt1 = 1) or late (d̂
opt
1 = −1) than mQ-probit for both outcomes ind_binge and
hs_util. However, Table 4.2 does not show a consistent and distinctive trend in either
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outcome comparing treatment regimes with early stage 1 intervention and treatment
regimes with late stage 1 intervention. Though we cannot validate the accuracy of es-
timating individualized optimal DTR, the marginal summary indicates that mQ-probit
generates a more reasonable result.
4.5 A Latent Variable Approach
The proposed modification in Section 4.2.2 improves Q-learning with probit regression
if residuals from stage 2 model is largely informative, but the improvement is limited,
and if misspecification of stage 2 main effect model does not deviate from reality much,
the proposed modification may be harmful to estimating the optimal rules. To further
improve the robustness of our algorithm, it is natural to consider the latent variable
approach. We propose a novel algorithm to optimize DTRs for dichotomous outcome
and explore the feasibility of using this framework to deal with informative residuals.
4.5.1 Framework
Let Y ∗ denote the latent continuous variable. The dichotomous outcome Y is defined
as
Y =
 1 if Y ∗ > ξ0 otherwise ,
where ξ is a known threshold of scientific choice.
In the literature of latent variable modeling (Skrondal and Rabe-Hesketh, 2004), the
expectation of the observed variable Y can be expressed as a function of the underlying
distribution of the latent variable Y ∗. Suppose Y ∗ = µ + ε and ε is independent and
identically distributed with mean 0 and variance σ2. Then
E(Y |µ) = P(Y = 1|µ) = P (Y ∗ > ξ|µ) = P (µ+ ε > ξ) = 1− Fε(ξ − µ), (4.4)
where Fε is the cumulative distribution function of ε.
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4.5.2 The Proposed Algorithm




21,iβ21. Following the formulation in Section 4.5.1, we derive
the log-likelihood of model parameters:










Now we propose a novel algorithm called modified latent Q-learning (mLQ) to op-
timize DTRs for dichotomous outcomes. Here is a brief outline of the proposed algo-
rithm. First, we utilize an Expectation-Maximization (EM) algorithm to estimate the
stage 2 model parameters θ = (β20,β21, σ). Using an idea adapted from Liu and Zhang
(2018), a surrogate of Y ∗ is drawn from the conditional distribution f(y∗|y) so that the
surrogate variable follows a distribution of
∑
y
f(y∗|y)f(y). Note that the marginal dis-
tribution f(y) is observed, but the conditional distribution f(y∗|y) can be misspecified.
We then use the surrogate variable and Murphy’s regret function to construct stage 1
pseudo-outcomes.
The detailed steps are as follows:
Stage 2 estimation: the EM algorithm
(mLQ-1) Initialize θ(v) for v = 0;
(mLQ-2) E-step: Take the expectation of ` (θ |{yi}ni=1, {y∗i }ni=1 ) over the conditional





























































































and φ(µ, σ2) and Φ(µ, σ2) denote the probability density function and cu-
mulative distribution function of N(µ, σ2) respectively;




































∣∣ yi)− 2 n∑
i=1






(mLQ-4) Iterate steps 2 and 3 until convergence, where the difference in log-likelihood
is negligible;






Stage 1 estimation: the linear model
(mLQ-6) Sample surrogate variables: Sample a surrogate of Y ∗i , denoted by si, for
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each individual from a truncated normal distribution conditional on yi,
f(y∗i |yi) = yiTN(µ̂i, σ̂2, ξ,∞) + (1− yi)TN(µ̂i, σ̂2,−∞, ξ),





(mLQ-7) Construct stage 1 pseudo-latent outcomes:
Ỹ ∗1i = si − 21
{
a2i 6= d̂opt2i
} ∣∣∣xT21,iβ̂21∣∣∣ ; (4.7)




∣∣∣H1i, A1i) = xT10,iβ10 + a1xT11,iβ11;






The EM algorithm is equivalent to probit regression in the prediction of stage 2 optimal
rules, but yields model estimates associated with the expectation of the latent variable.
The variance, or the standard error of the estimators can be obtained using Bootstrap.
4.5.3 Simulation Study Revisited
Following the simulation setting in Section 4.3, we add the performance of the proposed
mLQ. Figure 4.2 shows that mLQ has a consistent and moderately decent performance
across all γ’s. When a reasonably small amount of model misspecification is present,
specifically, for γ = 1, 2, 3, mLQ outperforms Q-probit and mQ-probit. However, when
a sizable amount of model misspecification is present (γ ≥ 4), mLQ starts to generate
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a lower accuracy in estimating stage 1 optimal rules than mQ-probit, but mLQ still
improves upon the standard Q-probit algorithm.
Figure 4.2: Probability of correctly identifying stage 1 optimal rules as a function of
σ for different values of γ using (1) Q-learning with probit regression, (2) modified
Q-learning with probit regression, and (3) modified latent Q-learning.
The intuition behind the moderate performance when stage 2 main effect model is
severely misspecified (or when stage 1 heterogeneous treatment effects of a considerably




f(y∗|y)f(y), where f(y∗|y) has a specified model, and f(y) is
observed and consistent with the truth. Thus, as γ increases, the misspecification of
the model f(y∗|y) starts to dominate the marginal distribution and reduce the accuracy
of estimating stage 1 optimal rules. However, mLQ still has a better performance than
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the standard Q-learning algorithm with probit regression due to the incorporation of
the observed distribution f(y).
4.5.4 Challenges with the Monotonicity Assumption
The latent variable approach generates estimates for the hidden continuous variable,
but we never get to observe them. If the underlying model of the latent variable Y ∗,
E (Y ∗|H2, A2) is misspecified, then we are not able to consistently estimate Ỹ ∗1 , as
the surrogates of the latent variable, si in Equation (4.7), are sampled from a semi-
misspecified model. Therefore, it remains a challenge to include the missing piece of
information discussed in Section 4.2.2.
Suppose the monotonicity assumption holds. At stage 2, if a subject received a
suboptimal treatment and responded with the desirable outcome Y = 0, then the
pseudo-outcome (conditional on stage 2 optimal rule) must have been Ỹ1 = 0. If a
subject received a suboptimal treatment and responded with the undesirable outcome
Y = 1, then the latent pseudo-outcome Ỹ ∗1 should follow a truncated normal distribu-
tion with an upper limit Y ∗i for each subject. The list of conditions is written down
mathematically below:
• If dopt2i = a2i, then Ỹ1i = Yi;
• If dopt2i 6= a2i and Yi = 0, then Ỹ1i = 0;
• If dopt2i 6= a2i and Yi = 1, then Ỹ ∗1i < Y ∗i .
The problem now comes down to the consistent estimation of Y ∗i . Moreover, one di-
rection of future work can be developing an algorithm by sampling directly from the
truncated normal distribution with a subject-specific upper limit Y ∗i , and comparing it
with mLQ, where the stage 1 latent pseudo-outcome is constructed using surrogates of
the unobservable latent variable and Murphy’s regret function.
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4.6 Discussion
This chapter serves as a first look at main effect model misspecification in Q-learning for
dichotomous outcomes, especially in terms of omitting stage 1 heterogeneous treatment
effects in the stage 2 model. We proposed modified Q-learning with probit regression
that corrects stage 1 pseudo-outcomes by imposing monotonicity-based restrictions. We
showed that the proposed approach led to an improved performance in estimating the
optimal DTR when model misspecification was considerably large. As the improvement
was limited when model misspecification was small due to some loss of information,
we explored the feasibility of a latent variable approach to increase sensitivity of the
algorithm, but figured that the approach did not solve the problem of systematic model
misspecification as the underlying continuous variable was unobservable. Moving for-
ward, we would like to further investigate a way to formalize residuals from the latent





As an emerging research area, there exists a rich body of literature discussing frameworks
and methods to study DTRs. Q-learning is one of the most popular amongst the rein-
forcement learning algorithms that were introduced to analyze adaptive interventions.
While many researchers dive into more advanced techniques such as machine learning to
address certain problems arisen with the implementation of Q-learning, the simpler and
more interpretable regression-based Q-learning has somehow been overlooked in recent
literature. The assumption that all Q-functions are correctly specified is indeed a strong
prerequisite for consistently estimating the optimal DTR, especially for studies where a
large number of features is considered. This thesis revisits regression-based Q-learning
and develops statistical methods in optimizing DTRs to improve clinical applicability.
This thesis has proposed multiple modifications of Q-learning to address three prob-
lems associated with its implementation to optimize DTRs. Here we provide a brief
recap. A Q-learning algorithm that posits a marginal model as the Q-function for each
stage and estimates model parameters using a generalized estimation equation was pro-
posed to generate individual or marginal trajectory of the optimal DTR that accounts for
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all repeated-measures times. One important message conveyed in the simulation study
was that, even though the partial correlation between repeated-measures outcomes can
be viewed as adding an unmeasured covariate to the expected outcome model, not ad-
justing for the unmeasured covariate is not harmful to estimation of the optimal rules.
This discovery motivated us to further explore the impact of omitted variables on stage
1 rule identification. We found that omission of stage 1 heterogeneous treatment effects
in stage 2 Q-function resulted in biased estimation of the stage 1 optimal rules. It is
also discussed in literature that stage 2 heterogeneous treatment effects cause bias un-
der misspecified stage 1 linearity due to the optimization operation. To address both
sources of bias concomitantly, we proposed a modified interactive Q-learning algorithm,
which is robust to both types of model misspecification. It is difficult to extend the
implementation of modified Q-learning to optimizing DTRs for dichotomous outcomes
due to the non-identity link. Thus, we proposed two alternative approaches to deal with
model misspecification in Q-learning with probit/logistic regression. The first approach
imposes some restrictions on stage 1 pseudo-outcomes based on monotonicity of pref-
erences, whereas the second approach utilizes a latent variable modeling and samples
surrogates of the underlying continuous outcome conditional on the observed dichoto-
mous outcomes. Both approaches cannot obviate specification of stage 2 Q-function, so
the proposed methods can only alleviate but not solve the problem.
5.2 Future Work
A major area of future work would be extending modified Q-learning to dichotomous
outcomes. In addition to the approaches explored in this thesis, other sampling meth-
ods, such as Bayesian techniques, may be applied. However, it might still remain a
problem to include late-stage informative residuals into early-stage pseudo-outcomes.
It would also be interesting to combine the proposed methods in Chapter 4 and inter-
active Q-learning for quantiles (Linn et al., 2017) to address the bias associated with
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heterogeneous treatment effects for dichotomous outcomes. Moreover, prior to data
manipulation, the frequency of binge drinking was originally recorded as an ordinal
outcome. The methods proposed in this thesis have the potential to be extended to
ordinal outcomes, and more modifications can be explored. One of my takeaways from
writing this thesis is there are much to explore in statistics and econometrics literature
that can be applied to practical problems in biostatistics. Furthermore, our work in
this thesis focuses primarily on point estimation and rule identification. Inference and
non-regularity has been a key problem for optimizing DTRs due to the non-smooth
absolute value function in the construction of stage 1 pseudo-outcome. The proposed
modifications should also be assessed in terms of statistical inference. Finally, a po-
tential research area would be integrating causal inference, optimization of DTRs, and
survival analysis to develop methodologies in oncology studies with treatment switch-
ing which invalidates randomization and the assumption of no unmeasured confounder.
The concept of dynamic treatment regimes and reinforcement learning can be applied
to inform the conditions (associated with potential tailoring variables) when patients
would benefit most from switching treatment.
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A.1 Inference for mQ-GEE
The estimators obtained from (modified) Q-learning with GEE are M-estimators, and
the asymptotics closely follow the inference for M-estimators under the restriction of
P(wT2 X21ψ2 = 0) = 0.
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and Y opt2i = X20,iβ2 − sgn{wT2 X21,iψ2}X21,iψ2.
Since sgn(x) =
{
−1 x < 0
1 otherwise
is discontinuous and non-differentiable at x = 0,
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β̂1 and ψ̂1 lose consistency and asymptotic normality under nonregular conditions at
wT2 X21,iψ2 = 0.
A.2 The DLD Study
Figure A.1: A sequential, multiple assignment, randomized trial for children with de-
velopmental language disorder (DLD). R indicates state of randomization with arrows
pointing to available treatment options, and A indicates time of assessment where
measurements of intermediate or final outcome take place.
The DLD study is proposed to evaluate a sequence of treatments for children with de-
velopmental language disorder (Finestack, 2018). The study uses an embedded tailoring
variable based on a child’s performance following an initial stage of treatment. Upon re-
cruitment, children will be randomized between two treatment arms: “Implicit-only,” in
which children are only provided with models and recasts of problematic forms at a high
frequency, and “Explicit-added,” where the pattern or pedagogic rule is directly pre-
sented. After stage 1 treatment, children are categorized as “Master” or “Non-master”
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based on their performance in target forms designed by the investigator. Masters will
be re-randomized to stop (“No additional”), boost (i.e., continue stage 1 treatment), or
switch to the alternative treatment, whereas non-masters will be randomized to boost or
switch. Similar to the M-bridge study, sustained performance after stage 2 is clinically
important; hence, the investigators also assess children’s performance at 1, 6, and 12
months after the treatment period.
A.3 Marginalization over an Unmeasured Covariate
Proposition 1. Suppose each element in a sequence of repeated-measures outcomes
(Y1, Y2, Y3) follows an independent normal distribution, Yij ∼ N(µj , σ2e) for subjects
i = 1, . . . , n and j = 1, 2, 3. Suppose the true mean µj is associated with a measurable
µ̃j and an additional unmeasured covariate Vi ∼ N(0, σ2v) and µj = µ̃j + λjVi. Then
the joint distribution of Y1, Y2, Y3 conditional on measurable µ̃1, µ̃2, µ̃3 is a multivariate




















































I3 is a 3× 3 identity matrix, the joint distribution of (Y1, Y2, Y3) conditional on µ̃ is
f(Y1, Y2, Y3|µ̃) =
∫ ∞
−∞



































(Y − µ)T (Y − µ) = (λ21 + λ22 + λ23)V 2 − 2V {λ1(Y1 − µ̃1) + λ2(Y2 − µ̃2) + λ3(Y3 − µ̃3)}
+ (Y1 − µ̃1)2 + (Y2 − µ̃2)2 + (Y3 − µ̃3)2.
Thus,

































b = σ−2e {λ1(Y1 − µ̃1) + λ2(Y2 − µ̃2) + λ3(Y3 − µ̃3)}
c = σ−2e
{
(Y1 − µ̃1)2 + (Y2 − µ̃2)2 + (Y3 − µ̃3)2
}
.
The function indicated by ζ in Equation (A.1) can be expanded and simplified as
ζ = σ−2e
{




3 − 2µ̃1Y1 − 2µ̃2Y2 − 2µ̃3Y3 −
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. Therefore, by the definition of multivariate
normal distribution, the distribution of Y conditional on measurable covariates has
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mean µ̃ and precision matrix
Σ−1 = σ−2e

1− ωλ21 −ωλ1λ2 −ωλ1λ3
−ωλ1λ2 1− ωλ22 −ωλ2λ3
−ωλ1λ3 −ωλ2λ3 1− ωλ23
 .
Finally, we obtain the desired covariance matrix by inverting the precision matrix.
A.4 Model Misspecifications in the Simulation Study
To apply Q-learning algorithms with GEE, we specify the Q-functions as
for t1 ∈ {1, 2, 3} and t2 ∈ {2, 3},
Qmis2 (H2, A2, t2;β2,ψ2) = β20,t2 + β21,t2Z1 + β22,t2A1 + β23,t2Y1
+A2 (ψ20,t2 + ψ21,t2Z1 + ψ22,t2A1 + ψ23,t2Y1) ,
Q2(H2, A2, t2;β2,ψ2) = β20,t2 + β21,t2Z1 + β22,t2A1 + β23,t2Z1A1 + β24,t2Y1
+A2 (ψ20,t2 + ψ21,t2Z1 + ψ22,t2A1 + ψ23,t2Y1) ,
Q1(H1, A1, t1;β1,ψ1) = β10,t1 + β11,t1Z1 +A1 (ψ10,t1 + ψ11,t1Z1) ;
whereas on the other hand, composite Q-learning fits
Qmis2 (H2, A2, t2;β2,ψ2) = β20 + β21Z1 + β22A1 + β23Y1
+A2 (ψ20 + ψ21Z1 + ψ22A1 + ψ23Y1) ,
Q2(H2, A2, t2;β2,ψ2) = β20 + β21Z1 + β22A1 + β23Z1A1 + β24Y1
+A2 (ψ20 + ψ21Z1 + ψ22A1 + ψ23Y1) ,
Q1(H1, A1, t1;β1,ψ1) = β10 + β11Z1 +A1 (ψ10 + ψ11Z1) .
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A.5 Relative Efficiency Using Different Working Correla-
tions
Misspecification of working correlation structures in GEE can cause loss in efficiency.
In this section, we assess the relative efficiency of using “unstructured”, “exchangeable”
and “independent” working correlations in stage 1 estimation. Estimates are the same
under different correlation structures due to the inclusion of time-varying coefficients,
but standard errors are different. So we use variance instead of MSE to quantify ef-
ficiency. Table A.1 summarizes the ratio of variances of τ̂j1(0) at time j, j = 1, 2, 3,
under different partial correlations. We assume there is not model misspecification in
this simulation. The λ’s specified in each scenario is summarized below:
1. Low positive partial correlation: λ1 = 1, λ2 = 0.2, λ3 = 0.2
2. Medium positive partial correlation: λ1 = 1, λ2 = 1, λ3 = 1
3. High positive partial correlation: λ1 = 1, λ2 = 3, λ3 = 1
4. Low negative partial correlation: λ1 = 1, λ2 = −0.2, λ3 = −0.2
5. Medium negative partial correlation: λ1 = 1, λ2 = −1, λ3 = −1
6. High negative partial correlation: λ1 = 1, λ2 = −3, λ3 = −1
7. Zero partial correlation: λ1 = 0, λ2 = 0, λ3 = 0
Note that “exchangeable” working correlation is the best choice for positive corre-
lations; “unstructured” working correlation is the best choice for negative correlations;
“independence” working correlation is the best choice for independent correlations.
Table A.1 shows that the relative efficiency does not change much across different
working correlations. For high positive partial correlations, “exchangeable” working
correlation seems to work slightly better than the other two options. For high negative
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partial correlations, “unstructured” working correlation work better than the other two
options for Q-GEE, but this pattern is not observed for mQ-GEE. An intuitive expla-
nation of this result is that the sample size n = 200 is relatively large compared to the
cluster size.
Partial Working Q-GEE mQ-GEE
Correlation Correlation Time 1 Time 2 Time 3 Time 1 Time 2 Time 3
Positive
Low
UN/IN 0.96 0.96 0.96 0.89 1.02 0.95
EX/IN 1.03 0.94 1.02 0.94 1.00 0.98
Med
UN/IN 0.95 0.98 1.08 0.88 1.03 0.89
EX/IN 1.01 0.96 1.04 0.93 1.05 0.92
High
UN/IN 0.97 1.06 1.04 1.02 0.88 0.89
EX/IN 0.95 0.96 0.99 0.98 0.91 0.94
Negative
Low
UN/IN 1.01 0.94 0.92 1.13 1.01 1.04
EX/IN 1.01 0.96 1.05 1.09 0.97 1.05
Med
UN/IN 0.99 0.95 0.90 0.93 1.05 1.09
EX/IN 0.95 0.86 0.97 0.99 0.96 1.01
High
UN/IN 0.84 0.93 0.93 0.98 1.06 1.08
EX/IN 0.92 1.10 1.04 0.97 1.01 1.10
Independent
UN/IN 0.95 1.04 1.05 0.95 0.99 1.06
EX/IN 0.91 0.97 1.03 0.91 1.01 1.02
Table A.1: Relative efficiency under correlation structures (1) unstructured (UN) and
(2) exchangeable (EX) versus independence (IN) respectively, based on a sample size of
n = 200 and 1000 simulations.
A.6 Simulation Study: Parsimonious Models
In Section 2.4, the simulation study considers a saturated model with time-varying co-
efficients. There is a tiny loss of accuracy in the estimation of stage 1 optimal rules
using Q-learning with GEE, and the loss pattern is consistent across different partial
correlations. One reasonable speculation of this finding is that the existence of addi-
tional time-varying coefficients in the marginal model inflates the estimation errors. We
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would like to investigate if Q-learning with GEE can possibly outperform standard Q-
learning when parsimonious model is considered. Suppose both Q-learning with GEE
and composite Q-learning fit parsimonious models with time-invariant coefficients:
Qmis2 (H2, A2, t2;β2,ψ2) = β20 + β21Z1 + β22A1 + β23Y1
+A2 (ψ20 + ψ21Z1 + ψ22A1 + ψ23Y1) ,
Q2(H2, A2, t2;β2,ψ2) = β20 + β21Z1 + β22A1 + β23Z1A1 + β24Y1
+A2 (ψ20 + ψ21Z1 + ψ22A1 + ψ23Y1) ,
Q1(H1, A1, t1;β1,ψ1) = β10 + β11Z1 +A1 (ψ10 + ψ11Z1) .
Consider (α1, α2, α3, γ2, γ3) = −(1.6, 1.6, 1.6, 1.2, 1.2) and rerun the simulation study
with the parsimonious models. In both scenarios, Q-GEE performs slightly better than
composite Q-learning for negatively (conditionally) correlated outcomes, but performs
much worse for positively correlated outcomes.
Partial Correlation Method PCI1 PCI2 RMSEτ11 RMSEτ12 RMSEτ13
Positive
Q 0.943 0.992 - - -
mQ 0.943 0.992 - - -
Q-GEE 0.888 0.992 3.18 (25.6) 3.18 (25.6) 3.18 (25.6)
mQ-GEE 0.941 0.992 0.72 (0.38) 0.72 (0.38) 0.72 (0.38)
Independent
Q 0.973 0.999 - - -
mQ 0.973 0.999 - - -
Q-GEE 0.972 0.999 0.36 (0.19) 0.36 (0.19) 0.36 (0.19)
mQ-GEE 0.972 0.999 0.36 (0.19) 0.36 (0.19) 0.36 (0.19)
Negative
Q 0.966 0.993 - - -
mQ 0.966 0.993 - - -
Q-GEE 0.967 0.993 0.40 (0.21) 0.40 (0.21) 0.40 (0.21)
mQ-GEE 0.967 0.993 0.41 (0.21) 0.41 (0.21) 0.41 (0.21)
Table A.2: (Scenario I) PCI of stage 1 optimal rules and RMSE (mean (SD)) of esti-
mated heterogeneous causal effects at time 2 and 3, based on estimated stage 1 parsi-
monious Q-functions from 1000 simulations with sample size n = 200.
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Partial Correlation Method PCI1 PCI2 RMSEτ11 RMSEτ12 RMSEτ13
Positive
Q 0.930 0.996 - - -
mQ 0.945 0.996 - - -
Q-GEE 0.871 0.996 3.47 (26.8) 3.47 (26.8) 3.47 (26.8)
mQ-GEE 0.943 0.996 0.71 (0.37) 0.71 (0.37) 0.71 (0.37)
Independent
Q 0.943 0.998 - - -
mQ 0.969 0.998 - - -
Q-GEE 0.911 0.998 1.93 (3.33) 1.93 (3.33) 1.93 (3.33)
mQ-GEE 0.968 0.998 0.42 (0.22) 0.42 (0.22) 0.42 (0.22)
Negative
Q 0.782 0.977 - - -
mQ 0.960 0.977 - - -
Q-GEE 0.824 0.977 2.39 (0.40) 2.39 (0.40) 2.39 (0.40)
mQ-GEE 0.962 0.977 0.49 (0.25) 0.49 (0.25) 0.49 (0.25)
Table A.3: (Scenario II) PCI of stage 1 optimal rules and RMSE of estimated het-
erogeneous causal effects at time 2 and 3, based on estimated stage 1 parsimonious
Q-functions from 1000 simulations.
A.7 Application: Model Fit and Variable Selection
We performed constrained variable selection based on QIC for both stage 1 and stage 2
saturated models (with time-varying coefficients), where the time-dependent effects of
A1 are forced in the stage 1 model and the time-dependent effects of A2 and A1 ∗A2 are
forced in the stage 2 model. Table A.4 shows a summary of the estimated parameters
using mQ-GEE, assuming equal weights for all three outcome measurements.




Continued on next page
1* p < 0.05, ** p < 0.01, *** p < 0.001
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Table A.4 – Continued from previous page
Estimate SE p-value
binge bl2 0.298 0.118 0.012 *
race(nonwhite) -0.415 0.242 0.086
time2 -0.381 0.146 0.009 **
time3 0.038 0.158 0.810
avg drinks bl3×time1 0.523 0.115 <0.001 ***
avg drinks bl×time2 0.185 0.053 <0.001 ***
avg drinks bl×time3 0.172 0.072 0.017 *
num days bl4×time1 0.072 0.066 0.270
num days bl×time2 0.007 0.035 0.850
num days bl×time3 0.092 0.055 0.092
intent greek(yes)×time1 0.585 0.438 0.181
intent greek(yes)×time2 -0.136 0.201 0.499
intent greek(yes)×time3 -0.382 0.297 0.198
race(nonwhite)×time2 0.407 0.231 0.078
race(nonwhite)×time3 0.070 0.245 0.775
Treatment Effects
A1×time1 -0.192 0.182 0.290
A1×time2 -0.068 0.124 0.583
A1×time3 -0.069 0.140 0.619
A1×gender(female) 0.105 0.142 0.460
A1×intent greek(yes)×time1 -0.465 0.411 0.258
A1×intent greek(yes)×time2 -0.154 0.197 0.433
A1×intent greek(yes)×time3 0.253 0.287 0.377
A1×race(nonwhite)×time1 0.287 0.239 0.229
A1×race(nonwhite)×time2 -0.032 0.143 0.824
A1×race(nonwhite)×time3 0.076 0.169 0.655
Stage 2 Model
Main Effects
Continued on next page
2Frequency of binge drinking during the last 30 days at baseline
3Average number of drinks consumed within a 24-hour period during the last 30 days at baseline
4Number of days using alcohol during the last 30 days at baseline
93
Table A.4 – Continued from previous page
Estimate SE p-value
binge bl 0.164 0.1224 0.181
gender(female) -0.674 0.2647 0.011 *
intent greek(yes) -0.661 0.3530 0.061
race(nonwhite) 0.557 0.5154 0.280
avg drinks bl 0.075 0.0678 0.272
binge sm5×time2 0.122 0.0594 0.040 *
binge sm×time3 0.184 0.0646 0.004 **
num days bl×time2 0.044 0.0592 0.457
num days bl×time3 0.117 0.0702 0.096
Treatment Effects
A2 -0.693 0.3320 0.037 *
A2×binge sm 0.116 0.0555 0.036 *
A2×num days bl 0.105 0.0513 0.041 *
A2×avg drinks bl 0.066 0.0681 0.335
A2×A1 -0.135 0.1614 0.401
A2×time3 -0.041 0.2357 0.862
A2×race(nonwhite)×time2 -0.734 0.5305 0.166
A2×race(nonwhite)×time3 0.825 0.6751 0.222
A2×binge bl×time2 -0.242 0.1307 0.064
A2×binge bl×time3 -0.371 0.1402 0.008 **
A2×A1×time3 -0.013 0.2213 0.955
5Frequency of binge drinking during the last 30 days at self-monitoring (stage 1)
Appendix B
Supplementary Materials for mIQ
B.1 Proof
Theorem 3.3.1 (Matrix Version of the Omitted Variable Bias Theorem). Suppose
that the true regression model for Y is Y = ψ0 + X
Tψ1 + V
Tγ + ε, where X is a
random vector formed by measured covariates, V is formed by unmeasured covariates,




are thus estimated via the misspecified model y = β0 + x
Tβ1 + ε
∗, where y and x are




 = ψ +
E(V T )− E(XT )Cov(X)−1Cov(X,V )
Cov(X)−1Cov(X,V )
γ.
Theorem 3.3.1 is developed based on the omitted variable formula and example in
Econometric Analysis by Greene (2002).
Proof. Let X denote a design matrix with xTi as the ith row, i = 1, . . . , n and y denote
a vector with yi as the ith element. Suppose that V is observable and let V denote
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squares estimator of β is β̂ = (X̃T X̃)−1X̃Ty.





Consider the multivariate regression V = λ0 +Λ1x+ε
∗∗, where ε∗∗ ∼MVN(0,Σ).
The least squares estimator of Λ =
λT0
ΛT1
 is Λ̂ = (X̃T X̃)−1X̃TV. Hence, E [(X̃T X̃)−1X̃TV] =
E(Λ̂) = Λ and E(β̂) = ψ + Λγ. Now, it remains to prove that
Λ =
E(V T )− E(XT )Cov(X)−1Cov(X,V )
Cov(X)−1Cov(X,V )
 .
The true values of Λ satisfy the equation
(λ0,Λ1) = arg min
Λ
E(V − λ0 −Λ1X)T (V − λ0 −Λ1X) = arg min
Λ
L.
The first derivative of L with respect to (λ0,Λ1) is
∂L
∂λ0
= −2E(V T ) + 2λT0 + 2E(XT )ΛT1 ,
∂L
∂Λ1
= −2E(XV T ) + 2E(X)λT0 + 2E(XXT )ΛT1 .
Hence, the score equations of (λ0,Λ1) are
S(λ0) = λ0 − E(V T ) + E(XT )ΛT1 = 0,
S(Λ1) =
[




E(XV T )− E(X)E(V T )
]
= Cov(X)ΛT1 − Cov(X,V ) = 0
Therefore, ΛT1 = Cov(X)
−1Cov(X,V ) and λT0 = E(V T )−E(XT )Cov(X)−1Cov(X,V ).
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Theorem 3.3.2 (Bias of Stage 2 Treatment Effect Estimators). Assume that V20 is a
vector of unmeasured covariates that are independent of A2 and Cov(X2) is invertible.
The estimators of stage 2 heterogeneous treatment effects are unbiased if and only if at
least one of the following conditions is satisfied:
• E(A2) = 0;
• V20 is correlated with neither X20 nor X21.





















 = 0⇐⇒ Cov(X20,V20) = 0 and Cov(X21,V20) = 0.
Suppose E(A2) = 0. Note that Cov(X20, A2X21) = E(A2)Cov(X20,X21) = 0.








Cov(X20) Cov(X20, A2) Cov(X20, A2X21)
Cov(A2,X20) Var(A2) Cov(A2, A2X21)

















. It follows that







Therefore, the estimators of stage 2 treatment effects, β̂210 and β̂211, are unbiased if
and only if E(A2) = 0 or Cov(X20,V20) = Cov(X21,V20) = 0.
Theorem 3.3.3 (Bias of Stage 2 Main Effect Estimators). Assume that V20 is a vector
of unmeasured covariates that are independent of A2 and E(A2) = 0. Suppose that V20
is correlated with X20 and Cov(X2) is invertible. Then the estimators of stage 2 main
effects are biased and the bias is B′γ20, where
B′ =























Cov(X20) Cov(X20, A2) Cov(X20, A2X21)
Cov(A2,X20) Var(A2) Cov(A2, A2X21)









































Proof. Let f(x) and F (x) be the probability density function and the cumulative dis-















































































B.2 Additional Results for Data Analysis
Method n1 Stage 1 Prediction n2 Stage 2 Prediction
d̂opt1 = −1 d̂
opt
1 = 1 d̂
opt




sQ 490 219 (44.7%) 271 (55.3%) 140 90 (64.3%) 50 (35.7%)
mQ 490 224 (45.7%) 266 (54.3%) 140 89 (63.6%) 50 (36.4%)
IQ 490 187 (38.2%) 303 (61.8%) 140 90 (64.3%) 50 (35.7%)
mIQ 490 181 (37.0%) 309 (63.0%) 140 90 (64.3%) 50 (35.7%)
byaacq
sQ 496 298 (60.1%) 198 (39.9%) 142 78 (54.9%) 64 (45.1%)
mQ 496 261 (52.6%) 235 (47.4%) 142 77 (54.2%) 65 (45.8%)
IQ 496 237 (47.8%) 259 (52.2%) 142 79 (55.6%) 63 (44.4%)
mIQ 496 229 (46.2%) 267 (53.8%) 142 77 (54.2%) 65 (45.8%)
Table B.1: Data analysis results using all four methods: sQ, mQ, IQ, and mIQ.
For the primary outcome max_drinks, standard Q-learning and the modified coun-
terpart with Murphy’s regret function generate similar results, indicating that the het-
erogeneity of stage 1 intervention effects is weak. However, there is a significant differ-
ence in the results between standard and interactive Q-learning, which might indicate
that the heterogeneity of stage 2 intervention effects is relatively stronger. For the sec-
ondary outcome byaacq, the results are distinctive across all four methods and may




C.1 The Manifest Distribution











1{yi = 1}1{y∗i > ξ}








yi1{y∗i > ξ}+ (1− yi)1{y∗i ≤ ξ}
]
where f denotes the probability density function and p denotes the probability mass
function.
The manifest distribution, or the marginal distribution of the response variable Y ,
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where Φ is the cumulative distribution function of a standard normal random variable.
C.2 Conditional Moments of the Latent Variable
In order to construct the EM algorithm, we need to derive the first and second moments
of the latent variable Y ∗ conditional on the manifest variable Y . As the value of Y
implies the truncation range of Y ∗, the distribution of Y ∗ conditional on Y is a truncated
normal distribution. The first moment, i.e. the expectation, of Y ∗ conditional on Y is
E (Y ∗|Y ) = µ+ (2Y − 1)σ
2φ(µ, σ2; ξ)
Y {1− Φ(µ, σ2; ξ)}+ (1− Y )Φ(µ, σ2; ξ)
, (C.1)




∣∣Y ) = µ2 + σ2 + (2Y − 1)(µ+ ξ)σ2φ(µ, σ2; ξ)
Y {1− Φ(µ, σ2; ξ)}+ (1− Y )Φ(µ, σ2; ξ)
, (C.2)
where φ(µ, σ2) and Φ(µ, σ2) denote the probability density function and cumulative
distribution function of N(µ, σ2) respectively.
We show the derivation of Equations (C.1) and (C.2) for the case of Y = 1 only,
and the derivation for the case of Y = 0 can be done similarly.
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E (Y ∗|Y = 1) = 1





























σ2φ(µ, σ2; ξ) + µ
{
1− Φ(µ, σ2; ξ)
}
1− Φ(µ, σ2; ξ)
= µ+ σ2
φ(µ, σ2; ξ)




∣∣Y = 1) = 1












1− Φ(µ, σ2; ξ)
{∫ ∞
ξ











1− Φ(µ, σ2; ξ)
}



























1− Φ(µ, σ2; ξ)
}




1− Φ(µ, σ2; ξ)
[
σ2ξφ(µ, σ2; ξ) + σ2
{




1− Φ(µ, σ2; ξ)
}
+ µσ2φ(µ, σ2; ξ)
]
= µ2 + σ2 + (µ+ ξ)σ2
φ(µ, σ2; ξ)
1− Φ(µ, σ2; ξ)
